US20040073206A1 - Surgical devices and methods for use in tissue ablation procedures - Google Patents
Surgical devices and methods for use in tissue ablation procedures Download PDFInfo
- Publication number
- US20040073206A1 US20040073206A1 US10/704,419 US70441903A US2004073206A1 US 20040073206 A1 US20040073206 A1 US 20040073206A1 US 70441903 A US70441903 A US 70441903A US 2004073206 A1 US2004073206 A1 US 2004073206A1
- Authority
- US
- United States
- Prior art keywords
- ablation
- tissue
- ablation probe
- heart
- conduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
- A61B2017/003—Steerable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
- A61B2017/0237—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for heart surgery
- A61B2017/0243—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for heart surgery for immobilizing local areas of the heart, e.g. while it beats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22051—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
- A61B2017/22065—Functions of balloons
- A61B2017/22067—Blocking; Occlusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B2017/320052—Guides for cutting instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
- A61B2018/0025—Multiple balloons
- A61B2018/00261—Multiple balloons arranged in a line
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00279—Anchoring means for temporary attachment of a device to tissue deployable
- A61B2018/00285—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00273—Anchoring means for temporary attachment of a device to tissue
- A61B2018/00291—Anchoring means for temporary attachment of a device to tissue using suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00875—Resistance or impedance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1475—Electrodes retractable in or deployable from a housing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Medical Informatics (AREA)
- Otolaryngology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Methods are provided to assist a surgeon in ablating conduction paths in tissue, such as a heart. In one embodiment, the invention presents a method that includes placing a guide in contact with the tissue to be ablated, applying an ablation probe to the tissue using the guide to assist in control of movement of the ablation probe, measuring the effectiveness of the ablation probe in ablation of the conduction paths, and deactivating the ablation probe when the measured effectiveness meets a desired level. Placement of the guide in contact with the tissue allows the surgeon to more easily sever the conduction path to form a lesion in a desired location.
Description
- This is a continuation of U.S. patent application Ser. No. 09/649,998, filed on Aug. 28, 2000, which claims priority to U.S. Provisional Application Serial No. 60/217,304, filed Jul. 11, 2000; U.S. Provisional Application Serial No. 60/206,081, filed May 22, 2000; U.S. Provisional Application Serial No. 60/190,411, filed Mar. 17, 2000; and U.S. Provisional Application Serial No. 60/181,895, filed Feb. 11, 2000, the entire content of each of which is incorporated herein by reference.
- The invention generally relates to surgical devices and, more particularly, to surgical devices and methods for use in procedures performed on moving tissue.
- Some forms of surgery involve ablation to kill tissue in an organ in order to achieve a therapeutic result. Ablation can be achieved by various techniques, including the application of radio frequency energy, lasers, cryogenic probes, and ultrasound. Thus, the term “ablation,” as used herein refers to any of a variety of methods used to kill tissue within an organ. To be successful, ablation treatment may require considerable precision. The surgeon must target a particular region, and be careful not to cause unnecessary trauma to other areas of the patient's body near the target area. Just as important, the surgeon must be confident that the procedure within the target area has been appropriately performed. For example, the surgeon may need to determine whether the tissue has been ablated to an appropriate degree. The surgery may be made more difficult if the target area is moving.
- One such surgical procedure in which a surgeon may wish to ablate moving tissue is an operation to correct an abnormal heartbeat. To function efficiently, the heart atria must contract before the heart ventricles contract. As blood returns to the heart and enters the atria, blood also flows through the atrioventricular (AV) valves and partially fills the ventricles. Following an electrical excitation by the sinoatrial (SA) node, the atria contract in unison, expelling blood into the ventricles to complete ventricular filling. The ventricles then become excited and contract in unison. Ventricular contraction ejects the blood out of the heart. Blood ejected from the right ventricle enters the pulmonary arteries for oxygenation by the lungs, and blood ejected from the left ventricle enters the main aorta and is distributed to the rest of the body. If the timing of cardiac functions is impaired, such as by the atria not contracting in unison or by the ventricles contracting prematurely, then the operation of the heart is impaired.
- The synchronization of heart functions is initiated by an excitation from the SA node, which is the heart's natural pacemaker. The excitation propagates along an interatrial pathway, extending from the SA node in the right atrium to the left atrium. The excitation then spreads across gap junctions throughout the atria, causing the atria to contract in unison. The excitation further travels down an internodal pathway to the AV node, which transmits the excitation to the ventricles along the bundle of His and across the myocardium via the Purkinje fibers. In an aging heart, the atria may stretch, and the conduction paths by which the excitations travel may become lengthened. As a result, the excitations have a longer distance to travel, and this may affect the timing of the heart contractions and may create an arrhythmia. The term “arrhythmia” is used to describe any variation from normal rhythm and sequence of excitation of the heart.
- One form of arrhythmia is atrial fibrillation. Atrial fibrillation is characterized by chaotic and asynchronized atrial cell contractions resulting in little or no effective blood pumping into the ventricle. Ventricular contractions are not synchronized with atrial contractions, and ventricular beats may come so frequently that the heart has little time to fill with blood between beats. Atrial fibrillation may occur if conduction blocks form within the tissue of the heart, causing the electrical excitations to degenerate into flurries of circular wavelets, or “reentry circuits,” which interfere with atrial activity. Initiation or maintenance of atrial fibrillation may be facilitated if atria become enlarged. Atrial enlargement increases the time required for the electrical impulse to travel across the atria. This allows sufficient time for the cells that contracted initially to repolarize and allows the re-entry circuit to be maintained.
- One surgical procedure for treating some forms of arrhythmia is to disrupt conduction paths in the heart tissue by severing the paths at selected regions of the atrial myocardium. Selective disruption of the conduction pathways permits impulses to propagate from the SA node to activate the atria and the AV node, but prevents the propagation of aberrant impulses from other anatomic sites in the atria. Severing may be accomplished, for example, by incising the full thickness of the myocardial tissue followed by closing the incision with sutures. The resultant scar permanently disrupts the conduction paths. As an alternative, permanent lesions, in which tissue is killed, can be created by ablation. The ablation process involves creating a lesion that extends from the top surface of the myocardium to the bottom surface (endocardial surface). Thus, the purpose of ablation is to create one or more lesions that sever certain paths for the excitations while keeping other paths intact. In the case of atrial fibrillation, for example, the lesions may interrupt the reentry circuit pathways while leaving other conduction pathways open. By altering the paths of conduction, the synchronization of the atrial contractions with the ventricular contractions may be restored. A plurality of lesions may be needed to achieve the desired results.
- Incision through the myocardium, referred to as the “maze procedure,” requires suturing to restore the integrity of the myocardium, and exposes the patient to considerable risk and morbidity. In contrast, thermal or other forms of ablation can create effective lesions without the need for sutures or other restorative procedures. Consequently, ablation can be performed more quickly and with far less morbidity. For these reasons, ablation is becoming a preferred method for severing conduction paths. The surgical ablation procedure may be performed during open-heart surgery. In a typical open-heart surgery, the patient is placed in the supine position. The surgeon must then obtain access to the patient's heart. One procedure for obtaining access is the median sternotomy, in which the patient's chest is incised and opened. Thereafter, the surgeon may employ a rib-spreader to spread the rib cage apart, and may incise the pericardial sac to obtain access to the cardiac muscle.
- For some forms of open-heart surgery, the patient is placed on cardiopulmonary bypass (CPB) and the patient's heart is arrested. CPB is preferred for many coronary procedures because the procedure is difficult to perform if the heart continues to beat. CPB, however, entails trauma to the patient with attendant side effects and risks.
- In some circumstances, the patient may be treated by a procedure less invasive than the procedure described above. One such less invasive procedure may be a lateral thoracotomy. The heart may be accessed through a comparatively small opening in the chest and accessed through the ribs. In such a procedure, arrest of the patient's heart may not be feasible, and if the heart cannot be arrested, the surgery must be performed while the heart continues to beat. Other procedures for access to the heart include stemotomy, thoracoscopy, transluminal, or combinations thereof.
- Once the surgeon has obtained access to the heart, ablation can be carried out with a probe that delivers ablative energy. The ablative energy may take the form of electromagnetic radiation generated by a laser or radio frequency antenna. Other techniques for achieving ablation include the application of ultrasound energy or very low temperature. For the procedure to be successful, the created lesions should sever the targeted conduction paths. Typically, the surgeon must create a lesion of a particular length to create the desired severance. The surgeon must also create a lesion of a particular depth in order to prevent the electrical impulses from crossing the lesion. In particular, when the myocardial tissue is ablated, the lesion must be transmural, i.e., the tissue must be killed in the full thickness of the myocardium to prevent conduction across the ablation line.
- The present invention is directed to surgical devices and methods useful in guiding surgical instruments during procedures on internal organs such as the heart. The device may take the form of a surgical “template” device that is attached to the surface of an organ. The device can be configured to facilitate surgical procedures such as tissue ablation. For example, a surgical template can be used as a guide for travel of a surgical or ablative probe along a path to aid a surgeon in ablation of tissue to sever conduction paths in the heart and thereby alleviate arrhythmia. A surgical template device may be especially useful in operations where the organ tissue being treated is moving, e.g., for so-called beating heart surgery. The surgical template device may be effective in providing local stabilization of the tissue to which the tissue ablation procedure is directed. The devices and methods also may find use in procedures in which the pertinent organ is not moving.
- Alternatively, the device may be configured to provide little or no stabilization, but provide guide structure for placement of the ablation probe in the same frame of motion as the moving tissue. In some cases, the template may incorporate hardware that structurally supports the instrument for travel along the ablation path. The template devices and methods can be configured for application of other types of therapeutic devices, such as diagnostic probes, pacing leads, and drug delivery devices, to the surface of a moving organ. To promote adhesion, in some embodiments, the device may be equipped with a compliant, tacky material that forms a seal for contact with tissue. The device also may be equipped with one or more vacuum ports that make use of vacuum pressure to enhance the attachment to the organ tissue. Adhesion refers to the ability of the device to hold fast to an organ on a temporary basis, either with the benefit of an adhesive or vacuum pressure or both. The present invention also is directed to surgical devices and methods useful in determining the effectiveness of a tissue ablation procedure. In some embodiments, a sensor may be integrated with a surgical template device as described above to assist the surgeon by making measurements that gauge whether the surgical procedure has been satisfactorily performed. For example, the surgical device may be configured to measure the effectiveness of an ablation procedure in terms of ablation length, depth or width. For example, the sensor may measure electrical characteristics of the tissue proximate the target conduction paths, e.g., tissue impedance, tissue conduction velocity, or tissue conduction time, as an indication of the effectiveness of the procedure. The information obtained by the sensor can be used as the basis for feedback to the surgeon, e.g., in audible and/or visible form. Moreover, the sensor information can be used as feedback for the closed-loop control of the tissue ablation probe. The sensor may be employed independently of a surgical template device.
- As a further aid to the surgeon, the surgical template device may include indicators such as visible markings that show the targeted length of the ablation. The visible markings can be used as a reference by the surgeon during movement of the ablation probe within the template area provided by the device. Also, the template device may include a structure that physically restricts the length of travel of the ablation probe, as well as the shape of the path along which the probe travels. In particular, the length indicator may include a stop structure that extends into the path for travel of the ablation device and is oriented for abutment with the ablation device. In some embodiments, for example, the ablation template device may provide a linear path for travel of the ablation probe. In other embodiments, however, the template device may define a non-linear, e.g., curved, path for travel of the ablation probe.
- Further, the present invention is directed to surgical devices and methods for manipulation of the heart and local stabilization of heart tissue for a tissue ablation procedure. In this aspect, the present invention may make use of a surgical template device that provides not only a guide for a tissue ablation procedure but also a structure that provides local stabilization of heart tissue within the operative area. In some embodiments, the ablation template device may be accompanied by a surgical manipulation device that adheres to the heart tissue and enables manipulation of the heart to provide the surgeon with a desired access orientation for the procedure. The manipulation device may permit lifting, pushing, pulling, or turning of the pertinent organ to provide the surgeon with better access to a desired area. For both the template and manipulation device, to promote adhesion, a compliant, tacky interface material can be provided for contact with tissue, along with one or more vacuum ports for use of vacuum pressure.
- In addition to providing a guide for a procedure, a template device and associated methods can be arranged to provide structure that supports instruments such as ablation probes, diagnostic probes, pacing leads, and drug delivery devices, for application to the surface of a moving organ and active guidance along a path. For some surgical procedures, it is necessary to bring surgical instruments into contact with the surface of a particular organ. In addition to the ablation application described above, one example is the placement of one or more electrodes within or in contact with organ tissue to deliver electrical impulses to the organ tissue for various purposes, such as a pacing to control the beating of the heart. Another example is the placement of a syringe needle to deliver a medicament to a specific location on an organ. Although all these procedures could be performed manually by the surgeon when the body cavity is opened during surgery, each is made more difficult when performed via a small opening in the body cavity, usually through an endoscopy port. Moreover, such procedures are particularly complicated when the surface of the pertinent organ is moving, as with a beating heart.
- Recently, some types of cardiac surgery have been performed through access ports or rather small incisions in the rib cage, instead of in the open field created by cutting through the sternum (a sternotomy) and spreading open the rib cage with a mechanical device. In these situations, there are occasions when surgical devices (diagnostic, therapeutic, etc.) will need to be affixed to a particular location on the heart surface without direct contact of the human hand. This might also be done while the heart is still beating. There is an increasing frequency of coronary artery bypass surgery done on beating hearts to avoid the morbidity associated with stopping the heart and placing the patient on cardiopulmonary bypass. Some surgeries on the beating heart are also performed using the traditional stemotomy. Access procedures such as stemotomy, thoracotomy, thoracoscopy, and percutaneous transluminal are contemplated.
- To facilitate such procedures, a template device is provided to fix a particular surgical tool or diagnostic or therapeutic device within a defined operative path for the tool or device. There are some surgical procedures performed on a beating heart, or other organ, that will require the fixation of a surgical instrument, diagnostic device or therapeutic device to accomplish a specific surgical procedure, diagnostic measurement, or delivery of some therapeutic product or method. This is particularly true when such procedures, measurements, or deliveries are performed under minimally invasive conditions, such as through narrow tubes or ports that penetrate the skin and enter the abdominal or thoracic cavities. Template devices and associated methods, in accordance with the present invention, are useful in guiding surgical instruments, certain diagnostic sensors, or mechanisms for delivery of medicaments on the surface of internal organs, such as the heart.
- The template devices and methods are particularly useful in attaching such instruments to the surface of the beating heart without any additional manual assistance of the surgeon, thereby facilitating certain procedures carried out both in open and minimally invasive procedures. Notable features of the template device include conformability to the contours of the organ, such as the heart, the ability to fix the device in place using vacuum, mechanical pressure, or adhesives, and atraumatic attachment by virtue of specific soft polymeric interfaces and shapes. The template device can be configured to attach to various surfaces of the heart using a vacuum seal. This device provides two or more vacuum ports surrounded by a conformable, compressible silicone gel or elastomer. As in the ablation template, these seals contain integrated electrodes for sending and receiving an electrical signal for the purpose of measuring impedance or conductance time or velocity across tissue in a treatment area. The electrodes may be surface or interstitial. Also, the electrodes may be multipolar, e.g., bipolar. In some embodiments, a single electrode within the seal may be sufficient with a reference electrode located elsewhere. A vacuum port or other fluid removal device may be desirable to remove fluids from the chamber to avoid the effects of such fluids on the electrical performance of the electrode(s) or electrical ablation devices. The ports can be attached to a single or multiple independent vacuum lines.
- In some embodiments of the invention, ablation is performed on the interior surfaces of the tissues. For example, an ablating instrument may be directed transluminally, such as by way of a catheter, near the ostia of the pulmonary veins in the left atrium of the heart. Following the ablation and creation of a lesion, electrodes delivered by the catheter may be used to measure the efficacy of the ablation.
- For radio frequency ablation, for example, enclosed in the body of the device can be a channel in which is located a moveable cable housing a radio frequency (RF) antenna for delivery of RF energy to the myocardium. The device allows the RF antenna to be moved by a remote control unit on the distal end of the cable. The cable can be moved through its channel by the controller in response to feedback from the sensors on the vacuum seals. As a lesion becomes transmural in one location, the sensors detect either decreases in impedance or increases in conduction time. This information is processed by the controller, and the RF antenna is moved by a motor that advances the cable assembly along a track in the device. Such a device is suitable for use in both open and minimally invasive procedures for the creation of linear transmural lesions for the treatment of atrial fibrillation.
- Another embodiment is a similar device, which contains malleable metal elements that allow the device to be formed into an arc (like a shepherd's crook) whose circumference can match the outer circumference of the base of the pulmonary vein. This device is similar in construction to the embodiment described above, except that it is attached to a rod suitable for insertion into a port access device for entry into the thorax or for manual manipulation by a surgeon in an open procedure. The device is brought into contact with the base of the pulmonary vein, and vacuum is used to attach it to a portion of the basal circumference of the vein. RF energy is delivered controllably as described above. When a full thickness lesion is created on one side of the vein, the vacuum is released, and the device moved so that its arc rests over the side of the vein that has not been treated. A full thickness lesion can then be created on that side.
- For some applications, the surgeon may manually control advance of the radio frequency antenna within the template device, and control further movement with a remote control device. In particular, the surgeon can also utilize manual movement of the RF antenna assembly through a joystick or other actuation transducer that advances the RF antenna. The joystick is operated by the surgeon in response to an indicator (light, etc.) that responds to the appropriate decrease in impedance or increase in conductance time detected by the sensors mounted in the vacuum seals. As an alternative, the surgeon may simply monitor the advance of the radio frequency antenna visually, and actuate a joystick or similar device. In either case, the template device operates as both a guide and an automated actuator to translate the radio frequency antenna (or other device) along a desired path. Notably, the template device is affixed to the pertinent tissue and provides automated movement of the instrument, reducing motion problems relative to the instrument offering enhanced precision.
- In one embodiment, the present invention provides a surgical device for use in a tissue ablation procedure. The device includes a contact member that engages the tissue near a location where the tissue is to be ablated. The contact member defines a guide that indicates, upon engagement of the contact member with the tissue, the location where the tissue is to be ablated, and provides a path for travel of a tissue ablation probe. The contact member of the device may include a compliant and tacky interface element for engagement with the tissue. The device may further define an interior chamber, and may include a vacuum port in fluid communication with the interior chamber. The interior chamber may be capable of delivering vacuum pressure to the contact member, thereby promoting vacuum-assisted adherence of the contact member to the tissue. In addition, the device may include a sensor that may indicate whether the desired degree of tissue ablation has been achieved.
- In another embodiment, the present invention provides an apparatus for determining whether conduction paths within heart tissue have been adequately ablated during a surgical procedure. The apparatus includes a first electrode capable of transmitting a first electrical signal adjacent the tissue to be ablated, a second electrode capable of receiving a second electrical signal adjacent the tissue to be ablated and a measuring device electrically coupled to at least the second electrode to receive the second electrical signal from the second electrode. The measuring device may determine whether the extent to which the tissue has been ablated to a sufficient degree based on the second electrical signal. The apparatus further includes an output device that provides an indication of extent, e.g., depth, to which the tissue is ablated. In order to measure impedance when using RF ablation, it may be necessary to use an energy frequency outside of the ablation energy frequency range or pulse or ablation energy and measure impedance during the quiescent period between ablation pulses.
- In another embodiment, the present invention provides a method for severing conduction paths within tissue. The method involves placing a first device near the target conduction paths to be severed, using the first device as a guide to sever the target conduction paths, and with a second device, measuring to determine whether the desired severing has been achieved. In this embodiment, the target conduction paths may be severed by tissue ablation. Measurement may involve determining whether the lesion depth is sufficient to sever the target conduction paths.
- The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects and advantages of the invention will be apparent from the description and drawings, and from the claims.
- FIG. 1 is a perspective view of an ablation template device in accordance with an embodiment of the present invention placed on a heart for purposes of illustration.
- FIG. 2 is an enlarged perspective view of an ablation template device as shown in FIG. 1, showing use of a surgical instrument.
- FIG. 3A is a top view of an ablation template device in accordance with an embodiment of the invention.
- FIG. 3B is a side view of an ablation template device in accordance with an embodiment of the invention.
- FIG. 3C is a cross-sectional side view of the device of FIGS. 3A and 3B.
- FIG. 4 is a conceptual diagram illustrating an ablation template device in accordance with an embodiment of the invention.
- FIG. 5 is another conceptual diagram illustrating an ablation template device in accordance with an embodiment of the invention.
- FIG. 6 is a perspective view of an ablation template device in accordance with an alternative embodiment of the invention placed on a heart for purposes of illustration.
- FIG. 7 is a top view of an ablation template device in accordance with an embodiment of the invention.
- FIG. 8 is a top view of an ablation template device in accordance with an embodiment of the invention.
- FIG. 9A is a perspective top view of an ablation template device in accordance with an embodiment of the invention.
- FIG. 9B is a perspective bottom view of an ablation template device as shown in FIG. 9A.
- FIG. 10 is a perspective view of an ablation template device in accordance with an embodiment of the invention.
- FIG. 11 is a perspective view of an ablation template device in accordance with an embodiment of the present invention, placed on a heart for purposes of illustration, used in cooperation with another device that permits manipulation of the heart.
- FIG. 12 is a cross-sectional side view of a cup-like manipulation device.
- FIG. 13 is a cross-section side view of another cup-like manipulation device.
- FIG. 14 is a perspective view of an ablation template device incorporating structure for accommodating an ablation probe;
- FIG. 15 is a cross-sectional view of the device of FIG. 14, taken at
point 145. - FIG. 16 is a cross-sectional view of a shaft incorporated in the device of FIG. 14, taken at point B.
- FIG. 17 is a perspective view of an arcuate ablation template device incorporating structure for accommodating an ablation probe.
- FIG. 18 is a perspective view of an added ablation template device incorporating structure for accommodating an ablation probe.
- FIG. 19 is a cross-sectional view of the device of FIG. 18, taken along line210-210′.
- FIG. 20 is a bottom view of the device of FIG. 18.
- FIG. 21 is a perspective view of an ablation template device incorporating a movable carriage for support of an ablation probe.
- FIG. 22 is a cross-sectional view of the device of FIG. 21, taken along line250-250′.
- FIG. 23 is a cross-sectional view of the device of FIG. 21, taken along line244-244′.
- FIG. 24 is a cross-sectional front view of an ablation template device having an internal ablation probe.
- FIG. 25 is a cross-sectional side view of the ablation template device of FIG. 24.
- FIG. 26 is a cross-sectional side view of a catheter-mounted ablation device.
- FIG. 27 is a side view of a catheter-mounted ablation device.
- FIG. 28 is a side view of a catheter-mounted ablation device.
- FIG. 29 is a cross-sectional side view of a catheter-mounted ablation device.
- FIG. 30 is a side view of a catheter-mounted ablation device.
- In general, like reference numerals are used to refer to like components.
- FIG. 1 is a perspective view of an
ablation template device 14 in accordance with an embodiment of the present invention. In FIG. 1,ablation template device 14 is shown placed on aheart 10 for purposes of illustration. In particular,heart 10 has been exposed by an open-chest surgical technique andablation template device 14 has been affixed to theright atrium 12 of the heart. In some embodiments,ablation template device 14 includes acontact member 17 that engages the tissue. In the example of FIG. 1,contact member 17 takes the form of a substantially ovular ring. Inner andouter diameters like contact member 17 define an annular chamber for engagement with tissue on the surface ofheart 10. -
Contact member 17 may be affixed to thesurface 15 ofatrium 12 in many ways, such as by application of an adhesive at the inner andouter diameters contact member 17 and thesurface tissue 15 is to include aseal member 23 formed from an adhesive material in the contact member. One example of an adhesive material is a coating of compliant, tacky material, such as silicone gel, at the interface between thecontact member 17 and the tissue on thesurface 15 ofatrium 12. In this case,contact member 17 may include asemi-rigid frame member 25 and a compliant, tacky seal member. The compliant,tacky seal member 23 provides intrinsic adhesive properties, and aids conformability and sealing to surface 15, while theframe 25 imparts structural integrity to contactmember 17. Each offrame 25 andseal member 23 has a substantially annular shape. In particular,seal member 23 may include inner andouter portions outer diameters contact member 17. - With a silicone gel, intrinsic adherence of
seal member 23 may be sufficient thatablation template device 14 remains affixed to theheart 10 in spite of contractions ofatrium 12 and in spite of the use ofdevice 14 in surgical procedures described below. Nevertheless, application of vacuum pressure will be desirable in many applications to provide secure adherence. Although the adherence should be secure, the adherence preferably is not permanent. Rather, adherence betweendevice 14 and the tissue may be discontinued as desired without serious trauma to the tissue, and the device repositioned and adhered anew at a different location. As an alternative,ablation template device 14 can be forced againstatrium 12 to provide pressure contact withheart 10. In such a case,ablation template device 14 may have a local stabilizing effect on the contact region ofheart 10 despite continued beating of the heart.Ablation template device 14 may be sized or shaped to allow it to mold to the contours of theatrium 12.Ablation template device 14 can be made principally of nonconductive materials, such as polyurethane, silicone, or natural or synthetic rubber. Shore A 50-80 silicone elastomer may be used, for example, to formframe 25 ofdevice 14. Metal such as annealed stainless steel or zinc or polymeric reinforcing members may be incorporated indevice 14, e.g., embedded within the molded elastomer, to resist excessive deformation or collapse during use. Shape memory alloys, in particular, may be useful in imparting a desired shape todevice 14 during use, and permit collapse and unfolding to the desired position for endoscopic deployment in minimally invasive techniques. - An
electrode 16 can be affixed todevice 14, e.g., withinseal member 23 orframe member 25, and placed in contact with thesurface 15 of theheart 10. Theelectrode 16 may send signals across the tissue of theheart 10 to be received by a second electrode (not shown in FIG. 1). These signals will traverse the tissue area being ablated. The associated circuitry for the electrodes may reachdevice 14 by way of aconnective tube 18. As will be described,electrode 16 may form part of a sensor for determining the effectiveness of a tissue ablation procedure. In particular, the electrodes can be used to measure electrical properties (such as impedance, phase angle, conduction time, conduction velocity, capacitance) of the local tissue area being ablated, and thereby indicate whether an effective lesion has been formed in the tissue. In some embodiments,ablation template device 14 may have multiple sets of electrodes situated at different positions along the major axis of the device. In this case, such electrodes may take the same types of measurements at different positions, or different types of measurements such as impedance, conduction velocity, and conduction time. - If
ablation template device 14 is attached with the assistance of vacuum pressure,connective tube 18 may also serve the purpose of attaching the interior chamber formed bycontact member 17 to an external source of vacuum pressure (not shown).Ablation template device 14 may be shaped to define an interior chamber that is enclosed upon engagement of the device with the tissue. In the example of FIG. 1, the chamber is substantially annular. Application of vacuum pressure may cause the enclosed chamber to slightly deform, creating a vacuum seal and causing thedevice 14 to become more affixed to the tissue. With added compliance fromseal member 23, in particular,contact member 17 can conform totissue surface 15 to achieve an effective seal. At the same time, thecompliant seal member 23 distributes sealing force across the tissue to reduce tissue trauma. - As shown in FIG. 1,
contact member 17 ofablation template device 14 generally may have a somewhat annular shape, with substantially oval-shaped inner and outer diameters, and anopening 31 through which the tissue ofatrium 12 may be accessed. The lengths of the major and minor axes of annular-shapeddevice 14 may vary to provideopening 31 with varying sizes according to the characteristics of the particular procedure to be performed. In some applications, opening 31 may define a narrow, linear track for travel of an ablation probe. In other applications, opening 31 may be much wider or define nonlinear tracks for travel of an ablation probe. Other shapes forcontact member 17 beside the annular shape may also be suitable. - A closer perspective view of
ablation template device 14 appears in FIG. 2. In FIG. 2, a surgeon'sfingers 24 hold a surgical instrument shown as an ablation probe 22 that may be used to ablate the tissue of theheart 10. Even though theheart 10 is beating, thesurgeon 24 may position the probe 22 within theopening 31 with relative ease. Thesurgeon 24 may also use the probe 22 to ablate a particular area of theatrium 12, even though theatrium 12 is in the process of contracting and relaxing, by using theinside edge 26 of thedevice 14 as a guide for travel of the probe. Again, opening 31 may define a substantially linear path for travel of an ablation probe. Alternatively, opening 31 can be non-linear, e.g., curved, or have other shapes appropriate for given surgical applications. In either case, the surgeon may use opening 31 as a guide, even resting the ablation probe 22 against theinside edge 26 ofcontact member 17 in some cases. Because significant heat may be generated by RF, laser, and ultrasonic energy, it may be desirable to provide ablation probe 22 with a thermally insulative sleeve that extends downward to the tip of the probe, thereby protecting theinside edge 26 ofcontact member 17. Also,inner edge 26 ofcontact member 17 can be coated with or coupled to an insulative material for contact with ablation probe 22. - If
ablation template device 14 is fixed to a point of reference, it may provide a local stabilizing effect that holds the tissue within opening 31 substantially stationary, or at least constrains the local area against excessive movement, despite continued beating ofheart 10. For example,ablation template device 14 may be pushed againstheart 10 to apply stabilizing pressure to the local area of contact. Alternatively,ablation template device 14 can make use of suction or adherence in combination with either a pushing or pulling force to provide a stabilizing effect. - Ablation probe22 may use a number of methods to achieve ablation. The probe 22 may, for example, use a laser to ablate tissue. As another alternative, the probe may incorporate an antenna that emits radio frequency (RF) energy to ablate tissue. The amount of power delivered by the ablation probe may vary. A typical RF probe, for example, may deliver from 5 to 50 watts. In this alternative, the probe 22 may include an electrode at its tip. An electrode can be provided within
ablation template device 14 to provide circuit completion for a probe using RF energy. For example, a passive electrode forming part of the sensor described above could be used as the return electrode. As a further alternative, probe 22 could take the form of an ultrasound probe that emits ultrasound energy, or a cryosurgical probe that cools the tissue to ultra-low temperatures. Thermal, chemical, and mechanical probes for obtaining or incising tissue are also contemplated. In each case, opening 31 ofablation template device 14 provides a guide for travel of probe 22, enabling greater precision in the ablation of conduction paths within the heart tissue. - Other views of
ablation template device 14 appear in FIGS. 3A and 3B. In these views, the device is shown in a top view, FIG. 3A, and a side view, FIG. 3B. FIG. 3C is a cross-sectional side view of the device of FIGS. 3A and 3B.Inner seal member 27 is indicated by dashedline 33. The interior chamber ofcontact member 17 is indicated byreference numeral 35.Ablation template device 14 may be flexible, and its relaxed shape may be curved as shown in FIG. 3B to more readily conform to the surface of the heart. The exemplary annular shape allowsfirst electrode 16 andsecond electrode 30 to be located opposite to each other across theopening 31. The distance between theelectrodes opening 31 preferably have sufficient rigidity to serve as a guide for travel of a probe or other surgical instrument. Althoughseal member 23 may be substantially compliant and conformable, the inner edge offrame member 25 may provide the degree of rigidity desirable to support the probe. In addition,ablation template device 14 may include one or several length indicators in the form ofvisible markings 28, to assist the surgeon in forming a lesion of a desired length. - A surgeon desiring to make a lesion of a particular length may use the
markings 28 as a guide for manipulating the probe. Thus, the guide provided by opening 31 is useful in guiding both the direction of travel of the probe and the extent of travel. Also, thetemplate device 14 may include a structure that physically restricts the length of travel of the ablation probe, as well as the shape of the path along which the probe travels. Substantially straight ablation tracks ordinarily will be desirable. Accordingly, the guide surface on the interior of the opening may be substantially straight. In other applications, however, it may be desirable to effect a curved ablation track. Therefore, the shape of the guide withinopening 31 may vary according to the application. Furthermore, because ablation typically causes a change in tissue color, themarkings 28 may provide the surgeon with information as to the actual length of the lesion. - In one aspect, the invention can be useful in determining whether the conduction path has indeed been cut. Ordinarily, a surgeon cannot visually gauge the depth of a lesion. The guide defined by
ablation template device 14 may provide an indication of the length of a lesion. A lesion of an insufficient depth may result in currents that pass under or over the lesion, however, and may thus be incapable of disrupting the reentry circuits or other undesirable current pathways. The myocardium consists of interlaced bundles of cardiac muscle fibers. Within the fibers, cardiac muscle cells are joined by intercalated discs, which include areas of low electrical resistance known as gap junctions. Gap junctions permit excitations or action potentials to propagate from one cell to another. A lesion created by ablation may destroy the tissue and the gap junctions, effectively interrupting electrical conduction. Thus, determination of whether the conduction paths are indeed ablated may be crucial to a successful treatment. - As shown in FIGS. 3A and 3B,
ablation template device 14 may include at least two electrodes, 16, 30 that operate as part of a sensor. A sensor may be used to indicate to the surgeon whether a desired degree of tissue ablation has been achieved.Electrodes ablation template device 14 to reduce the number of instruments that need to be introduced in to the surgical field. In particular,electrodes seal member 23 orframe member 25, and have conducting members that extend away from the tissue site viatube 18. A tip portion of each electrode may be exposed beyond the surface ofseal member 23 to enable sufficient electrical contact with the tissue to whichcontact member 17 is attached. - In other embodiments, however,
electrodes ablation template device 14. FIGS. 3A and 3B show an exemplary embodiment of the present invention, and other embodiments may incorporate more than two electrodes. After an ablation is performed inside theopening 31, and during ablation,electrodes electrodes electrodes - One way to make the determination is to use the
electrodes Electrodes - In addition to measuring impedance or as an alternative to measuring impedance, alternating current (ac) phase angle may be measured. In a capacitive circuit, the voltage lags the current, and the amount of lag is often expressed in the form of a phase angle. In a purely capacitive circuit, the voltage is 90° behind the current, expressed as a phase angle of −90°. A phase angle of 0° means the circuit is purely resistive. A phase angle between 0° and −90° means the circuit is partly resistive and partly capacitive. Typically a phase angle measurement across tissue will be between 0° and −90°, indicating some capacitive nature of the tissue. As ablation proceeds, cell membranes are ruptured, making the tissue less capacitive. Accordingly, the phase angle across the ablative lesion will become more positive (i.e., will approach zero) as cells die in the lesion. One way to determine whether the ablation is complete is to look for the point at which the phase angle measurement levels off. A baseline measurement of canine myocardium, for example, may show a phase angle of −13.1°. Measurements taken during the ablation may show the phase angle becoming more positive, eventually leveling off at −12° after about 20 seconds. As with impedance measurements, phase angle measurements are dependent upon many factors.
- Another way to make the determination is to use the electrodes to measure conduction distance by measuring conduction time. A signal traveling on a conduction path propagates as an action potential and propagates via gap junctions. The length of a conduction path, the speed of conduction and the time taken for a signal to travel the path are related by the simple formula:
- D=RT
- where D is the distance traveled by the signal, R is the rate of speed of the signal, and T is the time taken for the signal to travel the distance. In the case of an actual operation, a particular value of D or T may be desired. A value for R may be obtained by sending a test signal from one electrode, receiving it at the other electrode, the distance between the electrodes being known and relatively fixed, and measuring the time of conduction. In many cases, however, a relative measure of conductive velocity or time is sufficient, and therefore the distance between electrodes need not be known absolutely so long as it remains fixed. This measurement may then be used as a baseline measurement. Again, a baseline measurement may be desirable, because not all hearts have the same conduction speed, and different sections of a single heart may also have varying conduction speeds. The time of conduction may be measured again after the ablation is made and may be compared with the desired value of D or T. In general, conduction time increases and conduction velocity decreases as the ablation proceeds, and one way to determine whether the ablation is complete is to look for the point at which the measured quantity levels off. For example, a conduction time of 15 ms may be measured as a baseline. During ablation, conduction time may increase, eventually leveling off at around 30 ms. The leveling off indicates the ablation is transmural.
- In the case of measurement of conduction time, velocity, or distance,
electrode 30 may be a single electrode or a bipolar or multipolar electrode. Thus, in the description of this invention, it is to be understood that the transmittingelectrode 16 positioned on one side of the ablation track may be unipolar, while the measurement or “recording”electrode 30 positioned on the opposite side of the ablation track can be unipolar, bipolar, or multipolar, depending upon the electrical measurement that is utilized to determine if the conduction paths have been severed or ablation of the target tissue has been transmural, and desired precision. With aunipolar recording electrode 16, an electrical signal transmitted into the tissue by the transmitting electrode is first sensed as an electrical signal that is then followed by a depolarization wavefront that propagates through the cells disposed betweenelectrodes - A
unipolar recording electrode 30 simply measures whether the depolarization wavefront exceeds a given threshold. With abipolar recording electrode 30, however, the two electrodes can be used to measure current flow or a voltage potential between them. The two electrodes of thebipolar recording electrode 30 can be oriented in a line substantially parallel to the ablation track, and thereby form a “T” with the transmittingelectrode 16. As the depolarization wavefront propagates through the cells positioned between transmittingelectrode 16 andrecording electrode 30, the cells disposed between two recording electrodes ofbipolar recording electrode 30 depolarize, producing a difference in current flow between the two recording electrodes. This bipolar arrangement enables measurement of an increase in the intensity of current flow between the two electrodes ofbipolar recording electrode 30, and more precision in the measurement. In particular, an intensity threshold can be set. Conduction time can be measured between the time at which transmittingelectrode 16 transmits the initial signal and the time at which current flow between the two electrodes ofbipolar recording electrode 30 exceeds the threshold. Again, the initial signal transmitted by transmittingelectrode 16 and sensed by therecording electrode 30 can be ignored. Rather, the depolarization wavefront typically will be the event of interest in determining conduction time. - A method of using measurement of impedance or conductance variables to determine the transmurality of a lesion may also be employed using bipolar radio frequency electrosurgical ablation devices. For example, separate electrodes, using an electrical frequency different from the frequency used by the ablation device, can be mounted on the device and used to form a separate measuring circuit for impedance for the purpose of measuring the distance ablated. A typical bipolar device could have two electrode surfaces, one for one side of a tissue surface and one for the other side of a planar tissue surface, such as the myocardium, or a vascular structure. One transmitting electrode, or a plurality of electrodes, can be mounted with one of the surgical electrodes, and a receiving or “recording” electrode, which could be bipolar or multipolar, or a plurality of unipolar, bipolar, or multipolar electrodes, can be mounted on the opposite surgical electrode. Impedance or conductance, such as time, distance, or velocity, can be measured as described herein and can be used to determine transmurality, and shut off power to the ablation device as described. It is envisioned that one specific application of such a bipolar device would be for deployment through a puncture hole in the myocardium. The ablation device could be equipped with “jaws” that carry the electrodes. Entry of one of the “jaws” of the surgical RF device could be either from the endocardial or epicardial surfaces. After deployment, there would be a surgical electrode on both the epicardial surface and the endocardial surface. As RF power is supplied to the surgical ablation device, the tissue between the two surgical electrodes is heated and killed, creating a lesion for the purpose of interrupting conductance pathways. The transmurality of this lesion at different points along its length can be measured simultaneously or at time intervals during ablation using measurement of impedance or conductance variables with the separate circuits defined by the transmitting and recording electrodes placed along the path of the surgical electrodes and the underlying lesion.
- FIG. 4 shows a conceptual diagram of an implementation of an aspect of the invention.
Electrodes probes 34 for ameasurement device 36. Themeasurement device 36 may measure a quantity related to conduction, such as impedance or conduction time or conduction velocity. Data measured bymeasurement device 36 may be fed into aprocessor 38.Processor 38 may be in the form of a generalized computing device, such as a personal computer. Alternatively,processor 38 may be in the form of a smaller and more specialized computing device, such as a microprocessor or an application-specific integrated circuit. As a further alternative,processor 38 could be realized by discrete logic circuitry configured appropriately to perform the necessary measurement control and processing functions. Accordingly,processor 38 need not be embodied by integrated circuitry, so long as it capable of functioning as described herein. - In addition,
processor 38 may take an active role in the measurement process and may control measurements made bymeasurement device 36 throughprobes 34. In particular,processor 38 may control a current or voltage source to apply electrical current or voltage to one ofelectrodes processor 38 may actively control the measurement process are in the taking of a baseline measurement, and in the taking of periodic measurements during the ablation procedure to monitor progress.Processor 38 may further perform calculations as needed, and may provide output to the surgeon by way of anoutput device 40 such as a display. In addition,processor 38 may receive input from anadditional input device 42, which may include, for example, a keyboard or a touch screen. Usinginput device 42, the surgeon may, for example, input the length of a desired lesion, and theprocessor 38 may be able to provide feedback to the surgeon viaoutput device 40 as to whether the desired lesion has been created.Output device 40 may provide audible and/or visible output such as beeps, flashing light emitting diodes (LED's), speech output, display graphics, and the like, to provide feedback to the surgeon.Output device 40 can be mounted in a housing associated withprocessor 38, or integrated with the ablation probe 22. For example, one or more LED's could be mounted on the ablation probe in view of the surgeon. - FIG. 5 shows another conceptual block diagram of an implementation of an aspect of the invention. FIG. 5 is similar to FIG. 4, except that the
processor 38 is connected to theablation device 44.Ablation device 44 may be any device intended to sever conduction paths by killing tissue, such as the RF, laser, ultrasonic, or cryogenic probe 22 depicted in FIG. 2. In each case,ablation device 44 may be in the form of a powered instrument such as a laser, RF, or ultrasonic electrosurgical probe, or be coupled to a cryogenic supply.Processor 38 may controlablation device 44 by, for example, cutting off power or supply to the ablation device once the desired lesion has been created. In this manner, the surgeon can take advantage of closed-loop, real-time control of the output ofablation device 44, ensuring ablation to a proper level of effectiveness and avoiding excessive ablation. The result may be the creation of an effective lesion in a shorter time period, reducing the time necessary for access to the patient's heart tissue. The system may be even more effective if multiple electrode pairs are mounted along opening 31 to measure the effectiveness of ablation in creating a lesion along a continuous track. - The system shown in FIG. 5 may be useful for dynamic monitoring and control of the surgical procedure. The surgeon may choose an
ablation device 44, such as a laser, that will not interfere with the operation of theprobes 34. Alternatively, if interference is created by an RF probe, power can be intermittently turned off to enable measurement. By any combination of taking a baseline measurement or receiving input throughinput device 42, theprocessor 38 may determine what measurements received frommeasurement device 36 will satisfy the conditions for a successful surgical procedure.Processor 38 may continuously or frequently monitor the measurements received frommeasurement device 36 to determine whether the criteria for a successful surgical procedure have been met. When those criteria have been met,processor 38 may cut off power to, or otherwise interrupt the operation of,ablation device 44. In other words,processor 38 may use a feedback system as part of its control ofablation device 44 for either automated control or manual control by the surgeon. - One advantage of this system is the speed by which the surgeon may perform the ablation procedure. Speed is of a considerable advantage to the patient in several respects. First, risks attendant to surgery may be minimized if the time spent on the operating table is reduced. Second, a procedure performed on moving tissue such as a beating heart may be more efficient if done quickly.
- Once
ablation template device 14 is placed into position, a baseline measurement may be taken, and the surgeon may then proceed to make the ablation, usingablation template device 14 as a template or a guide. Use of thedevice 14 as a template or guide is one factor enhancing the speed of the procedure. The surgeon may usemarkings 28 onablation template device 14 to get a general idea of where to begin and end the ablation. Theprocessor 38 may be used to suggest to the surgeon viaoutput device 40suitable markings 28 for beginning and ending the ablation pass. The surgeon may then make a pass with theablation device 44. If the pass is too long, theprocessor 38 may interrupt the function of theablation device 44 before the pass is completed. If the pass is too short, theprocessor 38 may assist the surgeon in determining the best approach for a second pass. Again, the length determination may be aided by the use of a series of electrode pairs along an ablation track. The use of dynamic processing and feedback further enhance the speed of the procedure. FIG. 6 is a perspective view of anablation template device 50 in accordance with an alternative embodiment of the present invention. Likeablation template device 14 in FIG. 1,ablation template device 50 is shown placed on theright atrium 12 of aheart 10 in FIG. 6 for purposes of illustration. In particular,heart 10 has been exposed andablation template device 50 has been affixed to theright atrium 12 of the heart.Ablation template device 50 includes acontact member 51 which may engage and may be affixed to thesurface 15 ofatrium 12 by being pushed against the heart. Becauseablation template device 50 generally has a U-shaped shape,contact member 51 includes two contact tines or contact “feet” 53. - Electrodes used to take the measurements described herein may take the form of discrete electrodes that operate in pairs to transmit and receive signals across the ablated tissue region. Alternatively, one or more of the electrodes may take the form of bipolar or multi-polar electrodes that are integrated in a common electrode package and positioned in very close proximity to one another. With the closer spacing available in a bipolar package, for example, the signal transmitted by one electrode and received by the other as an EMG potential can be cleaner in terms of having a reduced degree of background noise due to surrounding electrical potentials produced by the heart. Instead, the bipolar electrode is capable of more effectively measuring the local signal conduction time. Also, in some embodiments, series of electrodes on each side of the ablation track can be realized by a continuous electrode component that includes conductive electrode regions and insulating regions disposed therebetween. Again, this sort of component can permit closer electrode spacing. In this case, however, the closer spacing is not between transmitting and receiving electrodes but between adjacent transmitting electrodes and adjacent receiving electrodes extending parallel to the ablation track. The closer spacing permits a higher degree of resolution in monitoring the progress of the ablation procedure along the ablation track, and thus the length of the resulting lesion. The closer spacing permits more precise feedback and control of the ablation probe by the surgeon or by an automated controller.
- To maintain its position relative to the
heart 10,ablation template device 50 may, in addition, have a compliant, tacky material such as silicone gel at the point of contact betweencontact member 51 and thesurface 15 of theatrium 12, providing a compliant, tacky interface.Ablation template device 50 may remain substantially affixed to theheart 10 in spite of contractions ofatrium 12 and in spite of the use ofablation template device 50 in surgical procedures described such as those described above. By being forced against the heart,ablation template device 50 may have a stabilizing effect on the contact region ofheart 10 despite continued beating of the heart.Shaft 52, made of a rigid material and formed in any suitable shape, may be used to pressablation template device 50 againstatrium 12 and hold the device in place. - Although
ablation template device 50 may be more rigid thanablation template device 14 in FIG. 1,ablation template device 50 may be sized or shaped to allow it to mold to the contours of theatrium 12. Likeablation template device 14 in FIG. 1,ablation template device 50 can be made (with the exception of the compliant, tacky interface) principally of substantially rigid, nonconductive materials, and may include afirst electrode 56 and a second electrode (not shown in FIG. 6). The associated circuitry for the electrodes may reachablation template device 50 by way ofshaft 52. The general U-shape ofablation template device 50 includes anopening 54 through which the tissue ofatrium 12 is accessible. The dimensions ofablation template device 50 andopening 54 may vary. Other shapes beside the U-shape may also be suitable for thedevice 50, such as the annular shape, and theopening 54 may be in other suitable shapes as well. - A top view of
ablation template device 50 appears in FIG. 7. The exemplary U-shape allowsfirst electrode 56 andsecond electrode 58 to be located opposite to each other across theopening 54. The distance between theelectrodes opening 54 have sufficient rigidity to serve as a guide for travel of a probe or other surgical instrument. In addition, likeablation template device 14,ablation template device 50 may includeseveral length indicators 64, to assist the surgeon in forming a lesion of a desired length. - A top view of a variation of
ablation template device 50 appears in FIG. 8.Ablation template device 50 is like the same device depicted in FIG. 7, except thefirst electrode 56 andsecond electrode 58 are not rigidly affixed to the body of thedevice 50.Electrodes ablation template device 50 by way ofelectrical connectors Electrical connectors electrodes electrical connectors electrodes ablation template device 50 is pressed against the tissue to enhance electrical coupling pressure and surface area. As shown in FIG. 8,electrodes opening 54.Electrodes - FIGS. 9A and 9B show an
ablation template device 69, which is similar to theablation template device 14 shown in FIG. 1. However, FIGS. 9A and 9B illustrates aframe member 75 and aseal member 77 in somewhat greater detail. FIG. 9A is a perspective top view ofdevice 69, while FIG. 9B is a perspective bottom view ofdevice 69. FIGS. 9A and 9B differ slightly in the shape ofdevice 69. Specifically,device 69 of FIG. 9A is shown as having a somewhat curved contour for conformability to the surface of the tissue. -
Frame member 75 can be formed from a semi-rigid material that lends structural integrity to contactmember 73, whileseal member 77 is formed from a more compliant material that facilitates conformance of the contact member to the tissue surface and promotes a seal that is generally atraumatic and more effective.Seal member 77 includes an inner skirt-like member 70 coupled to and extending around the inner edge ofcontact member 73 that acts as an interface with the tissue. Skirt-like member 70 may function in part as a seal gasket.Ablation template device 69 also includes an outer skirt-like member 72, coupled to and extending around the outer edge of thecontact member 73. Skirt-like members annular vacuum chamber 76. Inside of skirt-like member 70,contact member 73 defines opening 81 for access to a tissue site. Skirt-like members contact member 73. - Use of Shore A 5-10 durometer silicone elastomer for the skirt-
like member like members - Metal or polymeric reinforcing tabs can be incorporated in skirt-
like members like members frame member 75 can be molded about reinforcing tabs or springs, allowing a portion of the tabs or springs to extend downward, to one or both of the inner diameter or outer diameter side of the annular contact member. Then, one or both skirt-like members frame member 75, encasing the exposed portions of the tabs or springs. In the example of FIG. 9, outer skirt-like member 72 and the outer diameter side offrame member 75 are molded about and encase a continuous spring member, shown partially in FIG. 9 and indicated byreference numeral 79.Spring member 79 can be shaped from a continuous length or one or more segments of spring steel, or other materials capable of exerting a spring bias oncontact member 73. - When
ablation template device 69 is placed in contact with tissue, skirt-like members ablation template device 69 may include avacuum port 74. When vacuum pressure is supplied byconnective tube 71 to vacuumport 74, skirt-like members device 69 to the tissue. Upon application of vacuum pressure, skirt-like members vacuum chamber 76 having a substantially annular shape. Skirt-like members - FIG. 10 shows a perspective view of an
ablation template device 80, which is similar toablation template device 50 shown in FIG. 6. Thecontact member 82 of thedevice 80 has been supplied with a thin layer of a compliant,tacky substance 84 such as a silicone gel. Whenablation template device 80 is held by pressure againsttissue using shaft 86,tacky layer 84 may provide added adherence between the device and the tissue, and may reduce the risk of slippage. The tacky material may be included at every point of contact between the tissue andcontact member 82, or at selected sites of contact. - FIG. 11 is a perspective view of an
ablation template device 100, shown placed on aheart 10 for purposes of illustration.Ablation template device 100 is likeablation template device 69 shown in FIG. 9.Contact member 102 has been placed against thesurface 15 of theright atrium 12. Inner skirt-like member 104, extending around the inner edge ofcontact member 102, and outer skirt-like member 106, extending around the outer edge ofcontact member 102, assist in substantially affixingdevice 100 to theheart 10. Vacuum pressure supplied tovacuum port 108 via connectingtube 110 may promote additional adherence betweencontact member 102 andheart surface 15. - It may be difficult for a surgeon to obtain direct access to the tissue of the
atrium 12 where ablation is to be performed. It may be necessary for the surgeon to manipulate or move the heart so that access may be obtained. FIG. 11 illustrates the use of a surgical manipulatingdevice 120, whereby the apex 122 of theheart 10 is held and manipulated, allowing the surgeon to obtain access to the desired site on theatrium 12. It is known that some significant portion of the aberrant impulses responsible for atrial fibrillation can originate in myocardial cells that have migrated to the inner base of the pulmonary veins. Accordingly, it is important that ablation lines be drawn in such a way as to isolate the pulmonary veins and prevent those impulses from traveling into the atrial tissue. Accomplishing this isolation requires that the ablation lines be drawn relatively close to the base of the pulmonary veins. - The use of surgical manipulating
device 120 and similar devices described herein enables the surgeon to grasp the apex 122 of the beating or stoppedheart 10 and access the base of the pulmonary veins, e.g., by lifting, pulling, and/or turning the beating heart to expose the pulmonary veins. Important additional benefits ofdevice 120 and similar devices described herein may include the ability to lift and manipulate theheart 10 without causing significant trauma to the epicardium and with minimal or no disturbance of hemodynamics, reducing the overall risk of the procedure to the patient. Therigid handle 127 ondevice 120 permits the surgeon to apply axial (i.e., along axis from top of heart to apex) tension to the beating heart while lifting theheart 10 from the pericardial cavity. Maintaining axial tension while lifting the heart from the supine position to a position 90-110 degrees from the spine prevents distortion of valves and the decline in cardiac output that occurs when the heart is lifted by the surgeon's hand alone. - In some embodiments, two suction devices, e.g., like surgical manipulating
device 120, can be used to access the posterior of the heart and the base of the pulmonary veins. One device may be applied to the apex of the heart and the second device may be applied to a suitable location on the anterior surface of the heart, such as the area between the right and left ventricles (interventricular groove). Both devices can then be manually manipulated in concert so that the heart can be raised to a vertical position, i.e., close to 90 degrees from its ordinary anatomic orientation, without distorting the axis that runs from the apex to the great vessels. In addition, manual manipulation of both devices simultaneously permits the surgeon to move the raised heart from left to right inside the thoracic cavity. The use of the second device on the anterior surface of the heart keeps the chambers and valves in the heart from being compressed or distorted, and permits elevation and rotation of the heart without compromising blood flow. No decline in blood pressure (measured just below the aortic arch with an intravascular transducer) is observed when these manipulations are performed with the two devices used in concert. The two devices (each of which may conform substantially to device 120) can also be secured by a suitable clamp or frame that is anchored to the operating table or the chest retractor. - Manipulating
device 120, as shown in FIG. 11, may define a cup-like chamber 123 having avacuum port 125 coupled to avacuum tube 127.Chamber 123 can be formed from acup frame 121 formed with semi-rigid material and a compliant, tacky skirt-like member 129.Vacuum tube 127 may be coupled to an external vacuum source for delivery of vacuum pressure to the interior ofchamber 123. - Compliant, tacky skirt-
like member 129 can be formed, for example, from silicone gel, and can be attached to an outer wall defined bychamber 123 to provide a sealing interface with tissue atapex 122 ofheart 10.Skirt member 129 can be molded, cast, deposited or otherwise formed about the wall ofchamber 123, or adhesively bonded to the chamber wall. Although the tackiness ofskirt member 129 promotes adherence, adherence may be improved by application of the vacuum pressure viatube 127 andport 125. Upon application of vacuum pressure, at least a portion of theseal member 129 deforms and substantially forms a seal against the surface.Device 120, in various embodiments, may correspond substantially to similar devices described in the U.S. provisional application serial No. 60/181,925, filed Feb. 11, 2000, to Sharrow et al., entitled “DEVICES AND METHOD FOR MANIPULATION OF ORGAN TISSUE,” the entire content of which is incorporated herein by reference. - The
semi-rigid chamber 123 imparts structural integrity to thedevice 120, while the tacky, deformable material forming the skirt-like member 129 provides a seal interface with the heart tissue that is both adherent and adaptive to the contour of the heart. Moreover, as the skirt-like member 129 deforms, it produces an increased surface area for contact with the heart tissue. The increased surface area provides a greater overall contact area for adherence, and distributes the coupling force of the vacuum pressure over a larger tissue area to reduce tissue trauma. In general, the structure ofdevice 120 can be helpful in avoiding ischemia, hematoma or other trauma to theheart 10.Device 120 provides a grasping point, however, for manipulation ofheart 10 to provide better access to a desired surgical site, e.g., by lifting, turning, pulling, pushing, and the like. Once the desired presentation ofheart 10 is achieved usingdevice 120, the heart can be held relatively stationary, e.g., by fixingvacuum tube 127 to a more stationary object such as a rib spreader.Device 120 and similar devices described herein can be used to stabilize the heart in a similar manner by grasping the apex and/or other suitable locations on the heart, such as the anterior interventricular groove, and attaching the device to a stationary object. In this manner, it is possible to use one or more devices such asdevice 120 and similar embodiments in concert with the various embodiments of tissue ablation templates described herein placed at a variety of suitable locations on the heart to create a relatively stable epicardial surface for ablation. Such stabilization allows the surgeon to complete the manual ablation or other surgical procedures more easily and more quickly than without stabilization. For example, using afirst device 120 on a suitable ventricular surface and asecond device 120 on the apex permits the surgeon to elevate the heart and stabilize it to permit ablation with an ablation template on the posterior side of the heart. Addition of a flexible joint betweenvacuum tube 127 andmember 121 may allow the heart to maintain its normal movement resulting from contraction further reducing trauma to the heart. - In some embodiments,
device 120 and an ablation template device as described herein may be appropriately miniaturized to permit deployment via port-access methods, such as small thoracotomies. An ablation template device as described herein also could be appropriately miniaturized for application on the endocardial surface of the heart, e.g., using transluminal approaches. For endocardial application, an ablation probe such as an RF antenna can be integrated with the ablation template device, which could be made substantially flexible but incorporate shape memory elements or elasticity to expand following transluminal deployment. - In alternative embodiments, no external vacuum pressure need be applied. Instead, as shown in the cross-sectional side view of FIG. 12, a
device 120′ can be configured to incorporate a mechanical structure that permits variation of the volume within thechamber 123′, e.g., by actuation of a piston-like member or modulation of a fluid chamber. For example, ashaft 130 can be mounted withinchamber 123′ substantially wherevacuum port 125 andvacuum tube 127 are located in FIG. 11. Adistal end 131 of theshaft 130 is positioned to engage aflexible membrane 132 withinchamber 123′. An attachment pad can be placed betweendistal end 131 ofshaft 130 andflexible membrane 132 to permit adhesive or thermal attachment. Upon actuation of theshaft 130, themembrane 132 can be moved inward and outward relative to the interior ofchamber 123′, and thereby change the volume and, as a result, pressure within thechamber 123′. - As an illustration, upon engagement of
seal member 129 withheart 10,shaft 130 andcup 121 are pushed ontoheart surface 15. Retractingshaft 130 drawsmembrane 132 and heart surface 15 into the chamber defined bycup 121. Upon release ofshaft 130, elasticity ofmembrane 132 biases the membrane andshaft 130 back to their original positions, increasing the volume and decreasing the pressure withinchamber 123′. As a result,chamber 123′ produces a suction effect without application of external negative pressure that enhances the seal provided by the tacky skirt-like member 129. Thus, theshaft 130 andmembrane 132 can be used to create a negative pressure withinchamber 123′ that serves to aid adhesion of the tacky skirt-like gasket member 129 to apex 122 (shown in FIG. 11). FIG. 12 also illustrates internal attachment of skirt-like member 129 withcup frame 121. In particular, as shown in FIG. 12, skirt-like member 129 can be molded about theouter lip 133 ofcup frame 121. Also, aninsert 135 formed from a metal or polymeric material can be embedded withincup frame 121 and skirt-like member 129 to provide added structural integrity todevice 120′. - FIG. 13 illustrates another embodiment of a
device 120″ incorporating a limpet-like structure. In the example of FIG. 13, instead of ashaft 130 as shown in FIG. 12,chamber 123 receives afluid tube 134 atport 125.Fluid tube 134 permits inflow and outflow offluid 136 into theinternal cavity 138 defined bymembrane 132 and theinner wall 140 ofchamber 123. In this case,internal cavity 138 can be normally filled with a fluid 136 such as saline. When fluid is drawn fromdevice 120 throughfluid tube 134,membrane 132 is drawn towardport 125, decreasing the volume of theportion 138 ofchamber 123 that engagesheart 10. In this manner, pressure withinchamber 123 is reduced, creating a suction effect that aids the sealing pressure of skirt-like member 129 atapex 122. A stopping mechanism such as a valve or stopcock (not shown) may be employed to stop the flow of fluid throughfluid tube 134, and thereby fixing the sealing pressure. - FIG. 14 depicts a
device 141 that permits attachment of an antenna for delivery of radio frequency (RF) energy to the surface of a heart for the purpose of creating a linear lesion of dead tissue that is transmural. FIG. 15 shows a cross section atpoint 145 ondevice 140 of FIG. 14. Thebody 147 of thedevice 140 can be made of a suitable flexible polymeric material such as silicone elastomer. Ashaft 142, made of either a rigid or flexible material, depending upon application, can be used to position thedevice 140 in either an open or minimally invasive surgical procedure. The diameter ofshaft 142 would be sized differently for each of these applications. In the example of FIGS. 14 and 15,shaft 142 also contains a moveableinner catheter 143 that contains the RF antenna and, if appropriate, afluid delivery lumen 148. In addition to thecatheter 143,shaft 142 can provide a vacuum connection todevice 140, which may define one or more inner chambers. Thedevice 140 can be attached to the heart using twovacuum ports more seal members ports tubes shaft 142. - The
body 147 ofdevice 140 can be molded to define twovacuum chambers central lumen 158, which opens to abase side 160 of the device and forms a continuous track for accommodation ofcatheter 143.Malleable metal shafts body 147 to provide shaping capability and added structural integrity, but may not be necessary to achieve compatibility with all desired contours and positions on the heart. Vacuum pressure delivered throughvacuum chambers vacuum ports device 140 to the heart.Flexible seal members vacuum chamber seals Seal members - The
seal members fins material forming body 147 ofdevice 140 and integrally molded therewith.Seal members vacuum chambers body 147, likecentral lumen 158, to define elongated tracks. Upon application of vacuum pressure to vacuumports vacuum chambers device 140 tightly against the surface of the heart.Device 140 may be sized and structured to provide a local stabilizing effect on the tissue to which the device is attached, e.g., for beating heart surgical applications. In many embodiments, however, stabilization will not be necessary. Rather, it is sufficient thatdevice 140 fix a surgical instrument, e.g.,RF antenna 141, in the same frame of motion as the moving tissue. In this manner, an instrument can be applied with precision to the surface of the heart without significant relative motion. - In the
central lumen 158 is insertedcatheter 143, which, in the example of FIGS. 14 and 15, containsRF antenna 141.Antenna 141 may, itself, enclosefluid delivery lumen 148.RF antenna 141 is shown in FIGS. 14 and 15 at the end ofcatheter 143, where the antenna emerges at an angle to the catheter and protrudes through the track defined bycentral lumen 158 ofdevice 140. By slidingcatheter 143 along the track defined bylumen 158, thetip 182 ofantenna 141 can move along the track and deliver energy to the tissue with which it is in contact, creating a lesion that can extend the full thickness of the myocardium. An RF antenna is one example of an ablation probe suitable for use withdevice 140 to ablate tissue. Other ablation instruments could be placed incatheter 143, however, including laser, ultrasonic, and cryogenic probes, all, all of which could create a lesion in a similar fashion. - In some embodiments,
catheter 143 can be moved throughlumen 158 either manually by a surgeon by grasping the proximal end of the catheter or by a mechanical device connected to the catheter, e.g., at its distal end. For example, a variety of electrical motors could be used to drivecatheter 143 alongcentral lumen 158, e.g., directly via a worm gear drive or indirectly via pulley or gear arrangements. The motors can be driven either automatically, or at the direction of the surgeon using a joystick or other manual controls.Electrodes innermost seal members Electrodes conductors device body 147 and continue intoshaft 142.Electrode 184 andconductor 188 on one side of thedevice 140 can be used to send an electric signal across the lesion area formed byantenna 141 for detection on the other side of the device by anotherelectrode 186 andconductor 190. - FIG. 16 is a cross section at point B on
shaft 142 of FIG. 14.Conductors cable 192 to appropriate instrumentation. Such conductor/electrode sets can be used to measure impedance across the lesion or conduction velocity across the lesion. These measurements can be used to determine if the lesion is truly transmural, that it extends the full thickness of the myocardium.Conductors catheter 143 alongcentral lumen 158 when a transmural lesion has been created in one region. To that end, a plurality ofelectrodes central lumen 158 to take measurements at several positions along the length of the lesion track, thereby driving controlled advancement ofcatheter 143 as an effective lesion is formed at each position. Again, advancement ofcatheter 143 can be automated or manual. In either case the surgeon can be assured during the procedure that an effective lesion has been formed. - As shown in FIG. 16,
outer shaft 142 may contain twoseparate lumens chambers tubes bundle including conductors electrodes 184, 186 (FIG. 15). The number of conductors may be dependent upon the number of electrodes placed on each side of theinner sealing members electrode individual conductor central lumen 158 and coupled to a single conductor. In this case, a series of electrodes at various positions on one side ofcentral lumen 158 would transmit signals to the continuous electrode on the other side or vice versa.Catheter 143 fits in thecentral lumen 158 ofshaft 142 and, in this example, containsRF antenna 141 andfluid lumen 148. Again, other embodiments could have different types of ablation probes built intocatheter 143. - FIG. 17 shows a specialized form of a
device 140′ as shown in FIG. 14. In this embodiment, thedevice body 147′ is shaped in a substantially semicircular form to facilitate contact around the base of the pulmonary vein or similar structure.Device body 147′ is moved into position viashaft 142′ and vacuum is used to affix it to its first location on the vein. In this case, a catheter is translated around the arcuate path defined by a central lumen. The catheter carries an RF antenna or other ablation probe that is exposed via opening for contact with the outer wall of the pulmonary vein. Lesion generation is carried out on the full thickness of the vein wall in one location by energization of the RF antenna or activation of other suitable probe. As shown in FIG. 17, vacuum pressure can be applied viavacuum chambers 154′, 156′ withseal members 166′, 168′, 170′, 172′ providing an effective seal. When vacuum pressure is released,device 140′ can be moved viashaft 142′ to another location to create a lesion continuous with the previous one until a circumferential lesion is created all the way around the base of the pulmonary vein. As in the example of FIGS. 14-16,device 140 can be fixed in the same frame of motion as the pulmonary vein, eliminating significant relative motion to enhance precision in creation of the lesion. The interior ofdevice 140′ is identical to that ofdevice 140 as shown in FIG. 15, with two modifications. The malleable metal inserts 162, 164 are replaced with shaped memory metal inserts, which cause 140′ to assume an arcuate shape shown in FIG. 17.Malleable insert 163 is replaced with a semi-rigid metal rod which can be withdrawn throughshaft 142′ to allowelements cause device 140′ to also assume an arcuate shape. Insertion of the semi-rigid rod causesdevice 140′ to straighten into a linear shape that would permitdevice 140′ to entry into or withdraw from a tubular access port used in minimally invasive surgical procedures. - Although
device 140 is depicted as having a “shepherd's crook” shape, that shape is merely an exemplary embodiment of the invention. The ablative device may take other forms such as a loop, hook, ess or snare. In any of these configurations, electrode sets may be placed on the device so as to have a one or more transmitting electrodes on one side of the lesion and one or more receiving electrodes on the opposite side of the lesion to measure the effectiveness of the ablation. - FIGS.18-20 illustrate another embodiment of an
ablation template device 200. FIG. 18 is a perspective side view ofdevice 200. FIG. 19 is a cross-sectional side view ofdevice 200 taken at line 210-210′ in FIG. 18. FIG. 20 is a bottom view ofdevice 200. As shown in FIGS. 18-20,device 200 includes a ring-like contact member 202 defining an annular but generally oval-shapedchamber 204.Contact member 202 may include aframe 204 formed from a semi-rigid material, andseal members frame 204.Seal members vacuum tube 212 is mounted in avacuum port 214 that communicates with aninterior chamber 216 defined byframe 204 andseal members cover 218 can be mounted within thecentral aperture 220 defined byframe 204, or integrally formed with the frame, e.g., by molding. Cover 218 includes a slot-like track 222 that extends along the major axis ofcontact member 202.Track 222 accommodates anablation probe 224. -
Ablation probe 224 may take the form of an RF, laser, ultrasonic, or cryogenic probe, and includes upper andlower flanges upper flange 226 bears on an upper surface ofcover 218adjacent track 222, whilelower flange 228 bears on a lower surface of the cover.Ablation probe 224 is slidable alongtrack 222, however, to define a lesion path for an ablation procedure. In particular, a surgeon can simply slideablation probe 224 alongtrack 222.Electrodes track 222 can be electrically coupled to electronics that provide measurements, e.g., impedance, conduction velocity, and conduction time, to assess the effectiveness of the ablation procedure. In response to indications provided based on the electrode measurements, the surgeon advancesablation probe 224 alongtrack 222. Alternatively,ablation probe 224 can be advanced automatically alongtrack 222 in response to such indications. In some embodiments,tip 234 ofablation probe 224 may contact tissue. - FIGS.21-23 illustrate another
ablation template device 240. FIG. 21 is a partial perspective view ofdevice 240. FIG. 22 is a partial cross-sectional side view ofdevice 240 of FIG. 21 taken at line 242-242′. FIG. 23 is a cross-sectional front view ofdevice 240 of FIG. 21 taken at line 244-244′. As shown in FIGS. 21-23,device 240 includes acontact member 246 mounted on anelongated guide member 248 that extends throughbore 249.Contact member 246 may be slidable alongguide member 248 or fixed. The contact member includes aframe 250 formed of a flexible material, and aseal member 252 formed from a compliant, tacky material such as silicone gel. Theseal member 252 interfaces with tissue, e.g., on the surface of the heart.Frame 250 further defines one ormore rails 254 that extend radially outward relative to contactmember 246 and longitudinally relative to guidemember 248. Acarriage 256 is mounted onrails 254, e.g., via inner grooves that engage the rails, and defines alateral flange 258 designed to hold anablation probe 260. As shown in FIGS. 21 and 23, in particular,ablation probe 260 protrudes downward fromlateral flange 258 for contact with organ tissue. -
Ablation probe 260 can be molded into or otherwise encased inlateral flange 258 ofcarriage 256. A second lateral flange 262 (FIG. 23) can be provided, along with acounter probe 264, to contact tissue and thereby balancedevice 240 on a side ofcarriage 256 oppositelateral flange 258.Ablation probe 260 may take the form of an RF, laser, ultrasonic, or cryogenic probe designed to ablate tissue.Ablation probe 260 may have electric conductors that run along the length ofguide member 248 to an external power supply, in the case of an RF or ultrasonic probe. Alternatively, an optical fiber or fiber bundle may be coupled betweenablation probe 260 and an external source of laser energy. As a further alternative, a fluid line may extend between ablation stylus and a cryogenic source. In each case,device 240 can be sized and arranged to permit deployment by endoscopic or other minimally invasive techniques to an ablation site, e.g., on the surface of the heart. Thus, in one application,device 240 can be deployed and affixed to the surface of a beating heart, and fix theablation probe 260 in the same frame of motion as the heart. -
Seal member 252 may define a plurality ofvacuum ports 266 coincident with vacuum ports inguide member 248. A vacuum tube resides within aninner lumen 270 ofguide member 248 and includes one or more output ports that apply vacuum pressure to vacuumports 266. To perform an ablation procedure,device 240 is deployed to a desired site on the surface of an organ such as the heart. Vacuum pressure is applied to affixcontact member 246 to the tissue surface via the seal interface provided byseal member 252. At the same time,ablation probe 260 is brought in contact with the tissue surface.Ablation probe 260 is then energized to ablate the local tissue area proximate the tip of the probe. A guide wire or other elongated member can be coupled tocarriage 256, which preferably is slidable alongrails 254 defined bycontact member 252. By translating the guide wire,carriage 256 can be moved relative to contactmember 252 and thus relative to the tissue surface, thereby creating an ablation track. As in other embodiments, electrodes can be integrated withseal member 252 to measure the extent of ablation. Again, the measurements can be used as the basis for manual or automated control of the guide wire, and resulting movement ofcarriage 256. - FIGS. 24 and 25 illustrate another
ablation template device 272. FIG. 24 is a cross-sectional front view ofdevice 272, while FIG. 25 is a fragmentary cross-sectional side view.Device 272 is somewhat similar todevice 240 of FIGS. 21-23. However,device 272 need not incorporate a carriage. Rather,device 272 provides an internaloptical waveguide 274 mounted within aguide member 276 that transmits laser radiation.Waveguide 274 may be housed in acannula 278.Waveguide 274 may incorporate areflector 280 at itsdistal end 282 that reflects laser energy downward through a chamber defined byseal member 284 to ablate tissue.Seal member 284 may be substantially compliant and tacky and may be attached to asemi-rigid frame 286 that is coupled to or integrated withguide member 276.Cannula 278 andwaveguide 274 preferably are movable along the length ofguide member 276, as indicated byarrow 288.Optical waveguide 274 can be mounted within anouter vacuum lumen 290 that delivers vacuum pressure to affixdevice 272 to thetissue 292 viaseal member 284. To form an ablation track,optical waveguide 274 can be translated withinguide member 276, as indicated byarrow 288. Once again, electrodes can be integrated with seal member to enable manual or automated control of waveguide movement. - Ablation, and measurement of impedance or conduction time to assess ablation lesion depth, can also be performed along the interior surfaces of a structure. For example, a linear RF electrode can be transluminally introduced via a catheter into the atria of the heart and positioned on the endocardium in appropriate locations. Ablative energy from the RF electrode can then be applied. Electrode sets used to measure impedance or conduction time or other electrical properties can be integrated into the catheter body parallel to but insulated from the active RF electrode at the distal end of the catheter. These electrode sets can be utilized as described above to both measure lesion depth (from the endocardial to the epicardial surface) and to control delivery of energy.
- Transluminal introduction, therefore, represents an additional way to create a lesion around the base of the pulmonary veins, and thereby treat atrial fibrillation. The lesion may be created on the interior surfaces of the heart or pulmonary veins, rather than the heart's or veins' exterior surfaces. The treatment entails ablating the endocardial tissue near the ostia of the pulmonary veins in the left atrium. Typically the ablation apparatus is delivered to the site on the distal end of a steerable catheter introduced into the atrium or the pulmonary veins, and is manipulated and controlled at the proximal end of the catheter.
- FIG. 26 is a side view of an apparatus that may be directed transluminally near the ostia of the pulmonary veins in the left atrium. The device of FIG. 26 may conform substantially to the device shown in U.S. Pat. No. 5,938,660 to Swartz et al. In the example of FIG. 26, however, the device has been adapted in accordance with the present invention to incorporate components for measurement of ablation depth or effectiveness. In particular, electrodes have been positioned on the device so as to come into contact with tissue on opposing sides of a lesion created by the ablative components.
- FIG. 26 depicts a distal end of a
catheter body 300, withballoons catheter body 300 shown inflated. Fluid medium introduced throughcatheter lumen 306 at the proximal end emerges at the distal end throughopenings 308, thus inflating theballoons balloons Catheter 300 may include atip electrode 310 for sensing electrical activity.Catheter 300 may also includeRF electrode 312, which performs the actual ablation. Afterballoons catheter 300, which emerges at the distal end throughopenings 318. Application of RF energy follows, and the tissue between theballoons -
Electrodes balloons Electrodes RF electrode 312 andtip electrode 310.Electrodes electrodes Leads Leads electrodes catheter 300, and emerge from proximal end of catheter where leads are electrically coupled to a measuring device such as an impedance meter or conduction time measuring device. Following measurements that show a successful ablation, the conductive media may be withdrawn, balloons 302, 304 may be deflated, and the catheter may be extracted. - Many variations are possible. For example, a plurality of electrodes can be mounted on the surface of
balloons - FIG. 27 is a side view of an additional apparatus that may be directed transluminally near the ostia of the pulmonary veins in the left atrium. The device of FIG. 27 may conform substantially to the device shown in U.S. Pat. No. 6,024,740 to Lesh et al. and to the device shown in U.S. Pat. No. 6,012,457 to Lesh. In the example of FIG. 27, however, the device has been adapted in accordance with the present invention to incorporate components for measurement of ablation depth or effectiveness. In particular, electrodes have been positioned on the device so as to come into contact with tissue on opposing sides of a lesion created by the ablation element.
- FIG. 27 depicts a distal end of a
catheter 330, withballoon 332 on thecatheter body 330 shown inflated. Fluid medium introduced throughcatheter lumen 334 at the proximal end inflatesballoon 332, causingballoon 332 to lodge against the tissue, preferably but not necessarily at the ostia of the pulmonary veins.Catheter 330 may also includeRF electrode 336, which contacts the tissue.Catheter 330 may further include aproximal perfusion port 338 and adistal perfusion port 340 connected by aperfusion lumen 342. -
Electrodes balloon 332, and contact the tissue.Electrodes RF electrode 336.Electrodes electrodes electrodes catheter 330. At the proximal end of catheter, leads 348, 350 are electrically coupled to a measuring device such as an impedance meter or conduction time measuring device. Following measurements that show a successful ablation, theballoon 332 may be deflated and the catheter may be extracted. As with the apparatus shown in FIG. 26, many variations are possible. - FIG. 28 is a side view of a further apparatus that may be directed transluminally to various locations within either atrium. FIG. 28 depicts a distal end of a
catheter body 360.Catheter 360 is steerable, allowing it to be positioned against the tissue. An energy delivery means such as anRF electrode 362 performs the ablation. -
Electrodes lumens Electrodes Electrodes catheter 360, where they are electrically coupled to a measuring device such as an impedance meter or conduction time measuring device.Electrode tips electrode tips electrodes - FIG. 29 shows another apparatus that may be used transluminally in either atrium. The device of FIG. 29 may conform substantially to the device shown in U.S. Pat. No. 5,676,662 to Fleischhacker et al. In the example of FIG. 29, however, the device has been adapted in accordance with the present invention to incorporate components for measurement of ablation depth or effectiveness. In particular, electrodes have been positioned on the device so as to come into contact with tissue on opposing sides of a lesion created by the helical ablation element.
- FIG. 29 shows a distal end of a
catheter body 380.Catheter 380 is steerable, allowing it to be positioned against the tissue. An RF electrode 382 in the form ofhelical coils 384 performs the ablation.Coils 384 are electrically isolated from each other by an insulatingsubstance 386. -
Electrodes catheter 380 and are electrically isolated fromhelical coils 384.Electrodes catheter 380. At the proximal end of catheter, leads 392, 394 are electrically coupled to a measuring device such as an impedance meter or conduction time measuring device. - FIG. 30 is a side view of a further apparatus that may be directed transluminally, and may also be positioned on the atrial endocardium via thoracoscope or port access. The device of FIG. 30 may conform substantially to the device shown in U.S. Pat. No. 5,916,213 to Haissaguerre et al. In the example of FIG. 30, however, the device has been adapted in accordance with the present invention to incorporate components for measurement of ablation depth or effectiveness. In particular, electrodes have been positioned on the device so as to come into contact with tissue on opposing sides of a lesion created by the ablation elements.
- FIG. 30 depicts a distal end of a
steerable catheter body 400.Catheter 400 includes two energy delivery surfaces 402, 404 such as RF electrodes, which perform the ablation. Energy delivery surfaces 402, 404 are mounted onmovable arms Arms yoke 410, which is coupled to acable 412 leading to the proximal end of the catheter. By manipulation ofcable 412 andyoke 410,arms catheter body 400 and placed in a closed position parallel tocatheter body 400.Cable 412 may also be used to supply power to energy delivery surfaces 402, 404.Arms catheter body 400 and placed in an open position perpendicular tocatheter body 400. Whenarms catheter 400 can be steered to press energy delivery surfaces 402, 404 against the epicardium or endocardium. Once energy delivery surfaces 402, 404 are in place, energy may be applied to energy delivery surfaces 402, 404 to effect the ablation and create a lesion. -
Electrodes arm 406 andelectrodes arm 408.Electrodes electrodes electrodes Leads energy surface 402, and leads 426 and 428 carry information pertaining to the lesion created byenergy surface 404. - Many of the devices described above, such as those depicted in FIGS. 28, 29 and30, may be used with epicardial applications as well as endocardial applications. The devices described above may also be applied to tissues other than cardiac tissues. The electrode sets may be used with or without a surgical template. Although only one set of electrodes is shown in the figures for clarity, a plurality of electrode sets can be used in any embodiment. The electrode sets may be also be deployed independently of the ablative energy delivery system, and may be used with any ablative energy delivery system. Furthermore, in the devices described above, the electrode sets may be used as probes to control the delivery of energy as outlined in FIGS. 4 and 5. The specific embodiments described above are intended to be illustrative of the general principle and are not intended to be limited to a particular device or to a particular template or to a particular ablative energy delivery system.
- A number of embodiments of the present invention have been described. Other embodiments are within the scope of the following claims.
Claims (28)
1. A method for ablation of conduction paths within tissue comprising:
placing a first device near the target conduction paths to be severed;
using the first device as a guide for an ablation probe to sever the target conduction paths; and
measuring electrical tissue characteristics proximate the target conduction paths to determine whether the desired severing has been achieved.
2. The method of claim 1 , wherein the first device and the second device are coupled to one another.
3. The method of claim 1 , wherein measuring comprises measuring at least one of phase angle and impedance.
4. The method of claim 1 , wherein measuring comprises measuring at least one of conduction time, conduction distance or conduction velocity.
5. The method of claim 1 , further comprising comparing the desired degree of ablation with the measured degree of ablation.
6. The method of claim 1 , further comprising discontinuing ablation when the desired degree of ablation has been achieved.
7. The method of claim 6 , further comprising automatically discontinuing ablation when the desired degree of ablation has been achieved.
8. The method of claim 1 , further comprising applying vacuum pressure to the first device to secure the first device to the tissue near the target conduction paths to be served.
9. A method for ablating heart tissue to ablate conduction paths, the method comprising:
placing a guide in contact with the tissue to be ablated;
applying an ablation probe to the tissue using the guide to assist in control of movement of the ablation probe;
measuring the effectiveness of the ablation probe in ablation of the conduction paths; and
deactivating the ablation probe when the measured effectiveness meets a desired level.
10. The method of claim 9 , wherein measuring the effectiveness of the ablation probe in ablation of the conduction paths includes measuring at least one of electrical impedance, electrical phase angle, electrical conduction velocity, electrical conduction time, and electrical conduction distance across the tissue to be ablated.
11. The method of claim 9 , wherein measuring the effectiveness of the ablation probe in ablation of the conduction paths includes measuring impedance across the tissue to be ablated.
12. The method of claim 9 , wherein measuring the effectiveness of the ablation probe in ablation of the conduction paths includes measuring the phase angle across the tissue to be ablated.
13. The method of claim 9 , wherein the measurement is made using electrodes that are structurally integrated with the guide.
14. The method of claim 9 , wherein the ablation probe is deactivated automatically when the measured effectiveness meets a desired level.
15. The method of claim 9 , wherein measuring the effectiveness of the ablation probe in ablation of the conduction paths comprises:
making a plurality of measurements of electrical impedance across the tissue; and
monitoring a decrease in electrical impedance with the measurements.
16. The method of claim 15 , wherein deactivating the ablation probe when the measured effectiveness meets a desired level comprises deactivating the ablation probe when the decrease in electrical impedance discontinues.
17. The method of claim 9 , wherein measuring the effectiveness of the ablation probe in ablation of the conduction paths comprises:
making a plurality of measurements of a magnitude of an alternating current phase angle across the tissue; and
monitoring a change in the magnitude of the phase angle with the measurements.
18. The method of claim 17 , wherein deactivating the ablation probe when the measured effectiveness meets a desired level comprises deactivating the ablation probe when the change in the magnitude of the phase angle discontinues.
19. The method of claim 17 , wherein monitoring a change in the magnitude of the phase angle comprises monitoring a decrease in the magnitude of the phase angle.
20. The method of claim 9 , wherein measuring the effectiveness of the ablation probe in ablation of the conduction paths comprises:
making a plurality of measurements of conduction time; and
monitoring an increase in conduction time with the measurements.
21. The method of claim 20 , wherein deactivating the ablation probe when the measured effectiveness meets a desired level comprises deactivating the ablation probe when the increase in conduction time discontinues.
22. The method of claim 9 , further comprising applying vacuum pressure to the guide to secure the guide to the tissue.
23. A method for performing surgery on moving organ tissue comprising:
affixing a contact member on a moving tissue surface;
providing a surgical instrument that is attached to the contact member to place the surgical instrument in substantially the same frame of motion as the tissue surface; and
performing a surgical procedure with the surgical instrument.
24. The method of claim 23 , wherein the moving organ tissue is beating heart tissue.
25. The method of claim 23 , wherein the surgical instrument is an ablation probe, and performing the surgical procedure includes forming a tissue lesion with the ablation probe to sever desired conduction paths within the tissue.
26. The method of claim 25 , wherein the ablation probe includes one of a radio frequency, laser, ultrasonic, microwave, thermal, chemical, mechanical, and cryogenic ablation probe.
27. The method of claim 25 , further comprising moving the ablation probe along the tissue surface relative to the contact member to form the tissue lesion along a desired ablation track.
28. The method of claim 23 , wherein affixing the contact member on the moving tissue surface comprises applying vacuum pressure to the contact member to secure the contact member to the tissue surface.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/704,419 US20040073206A1 (en) | 2000-02-11 | 2003-11-07 | Surgical devices and methods for use in tissue ablation procedures |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18189500P | 2000-02-11 | 2000-02-11 | |
US19041100P | 2000-03-17 | 2000-03-17 | |
US20608100P | 2000-05-22 | 2000-05-22 | |
US21730400P | 2000-07-11 | 2000-07-11 | |
US09/649,998 US6663622B1 (en) | 2000-02-11 | 2000-08-28 | Surgical devices and methods for use in tissue ablation procedures |
US10/704,419 US20040073206A1 (en) | 2000-02-11 | 2003-11-07 | Surgical devices and methods for use in tissue ablation procedures |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/649,998 Continuation US6663622B1 (en) | 2000-02-11 | 2000-08-28 | Surgical devices and methods for use in tissue ablation procedures |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040073206A1 true US20040073206A1 (en) | 2004-04-15 |
Family
ID=27539057
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/649,998 Expired - Fee Related US6663622B1 (en) | 2000-02-11 | 2000-08-28 | Surgical devices and methods for use in tissue ablation procedures |
US10/158,435 Abandoned US20020143326A1 (en) | 2000-02-11 | 2002-05-28 | Surgical devices and methods for use in tissue ablation procedures |
US10/704,419 Abandoned US20040073206A1 (en) | 2000-02-11 | 2003-11-07 | Surgical devices and methods for use in tissue ablation procedures |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/649,998 Expired - Fee Related US6663622B1 (en) | 2000-02-11 | 2000-08-28 | Surgical devices and methods for use in tissue ablation procedures |
US10/158,435 Abandoned US20020143326A1 (en) | 2000-02-11 | 2002-05-28 | Surgical devices and methods for use in tissue ablation procedures |
Country Status (5)
Country | Link |
---|---|
US (3) | US6663622B1 (en) |
EP (1) | EP1253867A1 (en) |
AU (1) | AU2001236831A1 (en) |
CA (1) | CA2397370A1 (en) |
WO (1) | WO2001058373A1 (en) |
Cited By (135)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030181890A1 (en) * | 2002-03-22 | 2003-09-25 | Schulze Dale R. | Medical device that removably attaches to a bodily organ |
US20040254606A1 (en) * | 2003-06-10 | 2004-12-16 | Dan Wittenberger | Surgical clamp having trasmurality assessment capabilities |
US20050209589A1 (en) * | 2003-10-30 | 2005-09-22 | Medical Cv, Inc. | Assessment of lesion transmurality |
US20060015096A1 (en) * | 2004-05-28 | 2006-01-19 | Hauck John A | Radio frequency ablation servo catheter and method |
US20060235286A1 (en) * | 2005-03-28 | 2006-10-19 | Minnow Medical, Llc | Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures |
US20070149960A1 (en) * | 2003-06-10 | 2007-06-28 | Cryocath Technologies Inc. | Surgical clamp having transmurality assessment capabilities |
US20070156185A1 (en) * | 2001-12-04 | 2007-07-05 | Swanson David K | Ablative treatment of the heart to improve patient outcomes following surgery |
US20070185486A1 (en) * | 2004-05-28 | 2007-08-09 | Hauck John A | Robotic surgical system |
US20070181139A1 (en) * | 2004-05-28 | 2007-08-09 | Hauck John A | Robotic surgical system with contact sensing feature |
US20070185404A1 (en) * | 2004-05-28 | 2007-08-09 | Hauck John A | Robotic surgical system and method for diagnostic data mapping |
US20070185485A1 (en) * | 2004-05-28 | 2007-08-09 | Hauck John A | Robotic surgical system and method for automated creation of ablation lesions |
US20070198008A1 (en) * | 2004-05-28 | 2007-08-23 | Hauck John A | Robotic surgical system and method for automated therapy delivery |
US20070225558A1 (en) * | 2004-05-28 | 2007-09-27 | Hauck John A | Robotic surgical system and method for surface modeling |
US20080125772A1 (en) * | 2004-09-10 | 2008-05-29 | Minnow Medical, Inc | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US20080161801A1 (en) * | 2003-09-12 | 2008-07-03 | Minnow Medical, Inc. | Selectable Eccentric Remodeling and/or Ablation of Atherosclerotic Material |
US20090012510A1 (en) * | 2001-12-04 | 2009-01-08 | Endoscopic Technologies, Inc. | Cardiac ablation devices and methods |
US20090163910A1 (en) * | 2007-12-21 | 2009-06-25 | Sliwa John W | Template System and Methods |
US20090326439A1 (en) * | 2006-01-17 | 2009-12-31 | Cabochon Aesthetics, Inc. | High pressure pre-burst for improved fluid delivery |
US20100228182A1 (en) * | 2005-09-07 | 2010-09-09 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
WO2011112248A2 (en) * | 2010-03-08 | 2011-09-15 | Alpha Orthopaedics, Inc. | Methods and devices for real time monitoring of collagen and for altering collagen status |
WO2012019181A1 (en) * | 2010-08-06 | 2012-02-09 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US8155910B2 (en) | 2005-05-27 | 2012-04-10 | St. Jude Medical, Atrial Fibrillation Divison, Inc. | Robotically controlled catheter and method of its calibration |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8401667B2 (en) | 2008-11-17 | 2013-03-19 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US8439940B2 (en) | 2010-12-22 | 2013-05-14 | Cabochon Aesthetics, Inc. | Dissection handpiece with aspiration means for reducing the appearance of cellulite |
US8489192B1 (en) | 2008-02-15 | 2013-07-16 | Holaira, Inc. | System and method for bronchial dilation |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US8740895B2 (en) | 2009-10-27 | 2014-06-03 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8808280B2 (en) | 2008-05-09 | 2014-08-19 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8880185B2 (en) | 2010-06-11 | 2014-11-04 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9011473B2 (en) | 2005-09-07 | 2015-04-21 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9028472B2 (en) | 2011-12-23 | 2015-05-12 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US9186209B2 (en) | 2011-07-22 | 2015-11-17 | Boston Scientific Scimed, Inc. | Nerve modulation system having helical guide |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9248317B2 (en) | 2005-12-02 | 2016-02-02 | Ulthera, Inc. | Devices and methods for selectively lysing cells |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9272124B2 (en) | 2005-12-02 | 2016-03-01 | Ulthera, Inc. | Systems and devices for selective cell lysis and methods of using same |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9339618B2 (en) | 2003-05-13 | 2016-05-17 | Holaira, Inc. | Method and apparatus for controlling narrowing of at least one airway |
US9358064B2 (en) | 2009-08-07 | 2016-06-07 | Ulthera, Inc. | Handpiece and methods for performing subcutaneous surgery |
US9358033B2 (en) | 2005-09-07 | 2016-06-07 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9486270B2 (en) | 2002-04-08 | 2016-11-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for bilateral renal neuromodulation |
US9579030B2 (en) | 2011-07-20 | 2017-02-28 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9636173B2 (en) | 2010-10-21 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US9649156B2 (en) | 2010-12-15 | 2017-05-16 | Boston Scientific Scimed, Inc. | Bipolar off-wall electrode device for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9757193B2 (en) | 2002-04-08 | 2017-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatus for renal neuromodulation |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9808300B2 (en) | 2006-05-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US9827040B2 (en) | 2002-04-08 | 2017-11-28 | Medtronic Adrian Luxembourg S.a.r.l. | Methods and apparatus for intravascularly-induced neuromodulation |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US9919144B2 (en) | 2011-04-08 | 2018-03-20 | Medtronic Adrian Luxembourg S.a.r.l. | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
EP2632361B1 (en) * | 2010-10-28 | 2018-06-27 | Medtronic Ablation Frontiers LLC | Reactance changes to identify and evaluate cryo ablation lesions |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US10076238B2 (en) | 2011-09-22 | 2018-09-18 | The George Washington University | Systems and methods for visualizing ablated tissue |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10143517B2 (en) | 2014-11-03 | 2018-12-04 | LuxCath, LLC | Systems and methods for assessment of contact quality |
US10166069B2 (en) | 2014-01-27 | 2019-01-01 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US10188829B2 (en) | 2012-10-22 | 2019-01-29 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US10293190B2 (en) | 2002-04-08 | 2019-05-21 | Medtronic Ardian Luxembourg S.A.R.L. | Thermally-induced renal neuromodulation and associated systems and methods |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US10335280B2 (en) | 2000-01-19 | 2019-07-02 | Medtronic, Inc. | Method for ablating target tissue of a patient |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US20190343589A1 (en) * | 2016-12-16 | 2019-11-14 | University Of Ulsan Foundation For Industry Cooperation | Apparatus and method for manufacturing surgical guide, and surgical guide |
WO2019229430A1 (en) * | 2018-05-29 | 2019-12-05 | Ucl Business Ltd | Device for providing an interface between a medical instrument and a part of a human or animal body and methods of use thereof |
US10548663B2 (en) | 2013-05-18 | 2020-02-04 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10588682B2 (en) | 2011-04-25 | 2020-03-17 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US10589130B2 (en) | 2006-05-25 | 2020-03-17 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US10722301B2 (en) | 2014-11-03 | 2020-07-28 | The George Washington University | Systems and methods for lesion assessment |
US10736690B2 (en) | 2014-04-24 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US10736512B2 (en) | 2011-09-22 | 2020-08-11 | The George Washington University | Systems and methods for visualizing ablated tissue |
US10779904B2 (en) | 2015-07-19 | 2020-09-22 | 460Medical, Inc. | Systems and methods for lesion formation and assessment |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US10987164B2 (en) * | 2010-10-19 | 2021-04-27 | Michael D. Laufer | Methods and devices for diastolic assist |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US11096708B2 (en) | 2009-08-07 | 2021-08-24 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US11457817B2 (en) | 2013-11-20 | 2022-10-04 | The George Washington University | Systems and methods for hyperspectral analysis of cardiac tissue |
Families Citing this family (156)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6161543A (en) | 1993-02-22 | 2000-12-19 | Epicor, Inc. | Methods of epicardial ablation for creating a lesion around the pulmonary veins |
US6719755B2 (en) | 1996-10-22 | 2004-04-13 | Epicor Medical, Inc. | Methods and devices for ablation |
US6805128B1 (en) | 1996-10-22 | 2004-10-19 | Epicor Medical, Inc. | Apparatus and method for ablating tissue |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US7052493B2 (en) | 1996-10-22 | 2006-05-30 | Epicor Medical, Inc. | Methods and devices for ablation |
US8709007B2 (en) | 1997-10-15 | 2014-04-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Devices and methods for ablating cardiac tissue |
US8308719B2 (en) | 1998-09-21 | 2012-11-13 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Apparatus and method for ablating tissue |
US20070066972A1 (en) | 2001-11-29 | 2007-03-22 | Medwaves, Inc. | Ablation catheter apparatus with one or more electrodes |
US7004938B2 (en) * | 2001-11-29 | 2006-02-28 | Medwaves, Inc. | Radio-frequency-based catheter system with improved deflection and steering mechanisms |
WO2001005306A1 (en) | 1999-07-19 | 2001-01-25 | Epicor, Inc. | Apparatus and method for ablating tissue |
US6447443B1 (en) * | 2001-01-13 | 2002-09-10 | Medtronic, Inc. | Method for organ positioning and stabilization |
US6558382B2 (en) * | 2000-04-27 | 2003-05-06 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US6514250B1 (en) * | 2000-04-27 | 2003-02-04 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
US20030083654A1 (en) * | 2000-12-29 | 2003-05-01 | Afx, Inc. | Tissue ablation system with a sliding ablating device and method |
US20020087151A1 (en) * | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
US6761716B2 (en) * | 2001-09-18 | 2004-07-13 | Cardiac Pacemakers, Inc. | System and method for assessing electrode-tissue contact and lesion quality during RF ablation by measurement of conduction time |
US6652518B2 (en) * | 2001-09-28 | 2003-11-25 | Ethicon, Inc. | Transmural ablation tool and method |
US6695838B2 (en) * | 2001-09-28 | 2004-02-24 | Ethicon, Inc. | System and method for performing cardiac tissue ablation |
US7542807B2 (en) * | 2001-12-04 | 2009-06-02 | Endoscopic Technologies, Inc. | Conduction block verification probe and method of use |
US7226448B2 (en) * | 2001-12-04 | 2007-06-05 | Estech, Inc. (Endoscopic Technologies, Inc.) | Cardiac treatment devices and methods |
US7753908B2 (en) | 2002-02-19 | 2010-07-13 | Endoscopic Technologies, Inc. (Estech) | Apparatus for securing an electrophysiology probe to a clamp |
US7785324B2 (en) | 2005-02-25 | 2010-08-31 | Endoscopic Technologies, Inc. (Estech) | Clamp based lesion formation apparatus and methods configured to protect non-target tissue |
US7099717B2 (en) * | 2002-01-03 | 2006-08-29 | Afx Inc. | Catheter having improved steering |
US7831308B2 (en) * | 2002-02-01 | 2010-11-09 | The Cleveland Clinic Foundation | Neural stimulation delivery device with independently moveable delivery structures |
US7192427B2 (en) * | 2002-02-19 | 2007-03-20 | Afx, Inc. | Apparatus and method for assessing transmurality of a tissue ablation |
IL148791A0 (en) * | 2002-03-20 | 2002-09-12 | Yoni Iger | Method and apparatus for altering activity of tissue layers |
US6662054B2 (en) * | 2002-03-26 | 2003-12-09 | Syneron Medical Ltd. | Method and system for treating skin |
US7527634B2 (en) * | 2002-05-14 | 2009-05-05 | University Of Pittsburgh | Device and method of use for functional isolation of animal or human tissues |
US7063698B2 (en) | 2002-06-14 | 2006-06-20 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US7572257B2 (en) | 2002-06-14 | 2009-08-11 | Ncontact Surgical, Inc. | Vacuum coagulation and dissection probes |
US9439714B2 (en) | 2003-04-29 | 2016-09-13 | Atricure, Inc. | Vacuum coagulation probes |
US8235990B2 (en) * | 2002-06-14 | 2012-08-07 | Ncontact Surgical, Inc. | Vacuum coagulation probes |
US6893442B2 (en) | 2002-06-14 | 2005-05-17 | Ablatrics, Inc. | Vacuum coagulation probe for atrial fibrillation treatment |
US7250047B2 (en) * | 2002-08-16 | 2007-07-31 | Lumenis Ltd. | System and method for treating tissue |
CA2547587C (en) | 2002-11-27 | 2013-11-19 | Christopher Paul Hancock | Tissue ablating apparatus and method of ablating tissue |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US9462960B2 (en) * | 2003-02-21 | 2016-10-11 | 3Dt Holdings, Llc | Impedance devices and methods of using the same to obtain luminal organ measurements |
US20050010202A1 (en) * | 2003-06-30 | 2005-01-13 | Ethicon, Inc. | Applicator for creating linear lesions for the treatment of atrial fibrillation |
US20050038481A1 (en) * | 2003-08-11 | 2005-02-17 | Edward Chinchoy | Evaluating ventricular synchrony based on phase angle between sensor signals |
WO2005044124A1 (en) | 2003-10-30 | 2005-05-19 | Medical Cv, Inc. | Apparatus and method for laser treatment |
US7238179B2 (en) | 2003-10-30 | 2007-07-03 | Medical Cv, Inc. | Apparatus and method for guided ablation treatment |
US8162925B2 (en) * | 2003-11-07 | 2012-04-24 | Carnegie Mellon University | Robot for minimally invasive interventions |
US8052676B2 (en) | 2003-12-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Surgical methods and apparatus for stimulating tissue |
US8002770B2 (en) | 2003-12-02 | 2011-08-23 | Endoscopic Technologies, Inc. (Estech) | Clamp based methods and apparatus for forming lesions in tissue and confirming whether a therapeutic lesion has been formed |
US20050119653A1 (en) * | 2003-12-02 | 2005-06-02 | Swanson David K. | Surgical methods and apparatus for forming lesions in tissue and confirming whether a therapeutic lesion has been formed |
US7608072B2 (en) * | 2003-12-02 | 2009-10-27 | Boston Scientific Scimed, Inc. | Surgical methods and apparatus for maintaining contact between tissue and electrophysiology elements and confirming whether a therapeutic lesion has been formed |
US7371233B2 (en) * | 2004-02-19 | 2008-05-13 | Boston Scientific Scimed, Inc. | Cooled probes and apparatus for maintaining contact between cooled probes and tissue |
US8046049B2 (en) | 2004-02-23 | 2011-10-25 | Biosense Webster, Inc. | Robotically guided catheter |
JP2007529542A (en) * | 2004-03-18 | 2007-10-25 | セント・ルークス・ホスピタル | Method of delivering sustained release agent |
US7686803B2 (en) * | 2004-05-14 | 2010-03-30 | Cardima, Inc. | Ablation probe with stabilizing member |
WO2005115235A1 (en) | 2004-05-26 | 2005-12-08 | Medical Device Innovations Limited | Tissue detection and ablation apparatus and apparatus and method for actuating a tuner |
US20060069385A1 (en) * | 2004-09-28 | 2006-03-30 | Scimed Life Systems, Inc. | Methods and apparatus for tissue cryotherapy |
EP1799139B1 (en) * | 2004-10-05 | 2008-12-24 | Koninklijke Philips Electronics N.V. | Skin treatment device with radiation emission protection |
US20060116693A1 (en) * | 2004-12-01 | 2006-06-01 | Weisenburgh William B Ii | Apparatus and method for stone capture and removal |
US7727231B2 (en) * | 2005-01-08 | 2010-06-01 | Boston Scientific Scimed, Inc. | Apparatus and methods for forming lesions in tissue and applying stimulation energy to tissue in which lesions are formed |
US7776033B2 (en) * | 2005-01-08 | 2010-08-17 | Boston Scientific Scimed, Inc. | Wettable structures including conductive fibers and apparatus including the same |
US7862561B2 (en) * | 2005-01-08 | 2011-01-04 | Boston Scientific Scimed, Inc. | Clamp based lesion formation apparatus with variable spacing structures |
US7862562B2 (en) * | 2005-02-25 | 2011-01-04 | Boston Scientific Scimed, Inc. | Wrap based lesion formation apparatus and methods configured to protect non-target tissue |
US9031667B2 (en) * | 2005-03-04 | 2015-05-12 | InterventionTechnology Pty Ltd | Minimal device and method for effecting hyperthermia derived anesthesia |
US7588567B2 (en) * | 2005-04-22 | 2009-09-15 | Abl Technologies, Llc | Method and system of stopping energy delivery of an ablation procedure with a computer based device for increasing safety of ablation procedures |
US8696662B2 (en) | 2005-05-12 | 2014-04-15 | Aesculap Ag | Electrocautery method and apparatus |
US9339323B2 (en) | 2005-05-12 | 2016-05-17 | Aesculap Ag | Electrocautery method and apparatus |
US7803156B2 (en) * | 2006-03-08 | 2010-09-28 | Aragon Surgical, Inc. | Method and apparatus for surgical electrocautery |
US8728072B2 (en) | 2005-05-12 | 2014-05-20 | Aesculap Ag | Electrocautery method and apparatus |
US7862565B2 (en) | 2005-05-12 | 2011-01-04 | Aragon Surgical, Inc. | Method for tissue cauterization |
US8932208B2 (en) | 2005-05-26 | 2015-01-13 | Maquet Cardiovascular Llc | Apparatus and methods for performing minimally-invasive surgical procedures |
US8016822B2 (en) | 2005-05-28 | 2011-09-13 | Boston Scientific Scimed, Inc. | Fluid injecting devices and methods and apparatus for maintaining contact between fluid injecting devices and tissue |
US8945151B2 (en) | 2005-07-13 | 2015-02-03 | Atricure, Inc. | Surgical clip applicator and apparatus including the same |
US8157818B2 (en) | 2005-08-01 | 2012-04-17 | Ension, Inc. | Integrated medical apparatus for non-traumatic grasping, manipulating and closure of tissue |
US7918847B2 (en) * | 2005-08-29 | 2011-04-05 | Washington University | Method and associated system for the interventional treatment of atrial fibrillation |
US8721597B2 (en) | 2006-11-09 | 2014-05-13 | Ncontact Surgical, Inc. | Diaphragm entry for posterior surgical access |
US9808280B2 (en) * | 2005-10-12 | 2017-11-07 | Atricure, Inc. | Diaphragm entry for posterior surgical access |
US8211011B2 (en) | 2006-11-09 | 2012-07-03 | Ncontact Surgical, Inc. | Diaphragm entry for posterior surgical access |
US9561044B2 (en) | 2005-10-12 | 2017-02-07 | Atricure, Inc. | Diaphragm entry for posterior surgical access |
EP1956992B1 (en) * | 2005-12-02 | 2013-03-06 | Koninklijke Philips Electronics N.V. | Automating the ablation procedure to minimize the need for manual intervention |
US8603084B2 (en) | 2005-12-06 | 2013-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the formation of a lesion in tissue |
BRPI0619725A2 (en) | 2005-12-06 | 2011-10-11 | St Jude Medical Atrial Fibrill | tissue ablation electrode junction evaluation |
US9492226B2 (en) | 2005-12-06 | 2016-11-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Graphical user interface for real-time RF lesion depth display |
US10362959B2 (en) | 2005-12-06 | 2019-07-30 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing the proximity of an electrode to tissue in a body |
US8406866B2 (en) | 2005-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing coupling between an electrode and tissue |
US8403925B2 (en) | 2006-12-06 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for assessing lesions in tissue |
US9254163B2 (en) | 2005-12-06 | 2016-02-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
CA2638029A1 (en) * | 2006-01-27 | 2007-08-09 | Medtronic, Inc. | Ablation device and system for guiding said ablation device into a patient's body |
KR100799524B1 (en) * | 2006-02-28 | 2008-01-31 | 전용규 | An applicator in a device for treating skin |
US7662177B2 (en) | 2006-04-12 | 2010-02-16 | Bacoustics, Llc | Apparatus and methods for pain relief using ultrasound waves in combination with cryogenic energy |
US8574229B2 (en) | 2006-05-02 | 2013-11-05 | Aesculap Ag | Surgical tool |
US20070299393A1 (en) * | 2006-06-23 | 2007-12-27 | Podmore Jonathan L | Device and method for surgical treatments |
WO2008027366A2 (en) * | 2006-08-28 | 2008-03-06 | Vascular Precision | Devices and methods for creating and closing controlled openings in tissue |
WO2008063195A1 (en) * | 2006-10-12 | 2008-05-29 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Assessment of electrode coupling for tissue ablation |
US10166066B2 (en) | 2007-03-13 | 2019-01-01 | University Of Virginia Patent Foundation | Epicardial ablation catheter and method of use |
US9468396B2 (en) | 2007-03-19 | 2016-10-18 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
EP2134253B1 (en) | 2007-03-19 | 2022-01-26 | University Of Virginia Patent Foundation | Access needle pressure sensor device |
US11058354B2 (en) | 2007-03-19 | 2021-07-13 | University Of Virginia Patent Foundation | Access needle with direct visualization and related methods |
US9211405B2 (en) | 2007-03-22 | 2015-12-15 | University Of Virginia Patent Foundation | Electrode catheter for ablation purposes and related method thereof |
EP3025636B1 (en) | 2007-05-11 | 2017-11-01 | Intuitive Surgical Operations, Inc. | Visual electrode ablation systems |
US8628522B2 (en) * | 2007-05-21 | 2014-01-14 | Estech, Inc. (Endoscopic Technologies, Inc.) | Cardiac ablation systems and methods |
US8202272B2 (en) | 2007-07-19 | 2012-06-19 | Avedro, Inc. | Eye therapy system |
US8992516B2 (en) | 2007-07-19 | 2015-03-31 | Avedro, Inc. | Eye therapy system |
EP2209517A4 (en) | 2007-10-05 | 2011-03-30 | Maquet Cardiovascular Llc | Devices and methods for minimally-invasive surgical procedures |
US20100241185A1 (en) | 2007-11-09 | 2010-09-23 | University Of Virginia Patent Foundation | Steerable epicardial pacing catheter system placed via the subxiphoid process |
US8353907B2 (en) * | 2007-12-21 | 2013-01-15 | Atricure, Inc. | Ablation device with internally cooled electrodes |
US8998892B2 (en) | 2007-12-21 | 2015-04-07 | Atricure, Inc. | Ablation device with cooled electrodes and methods of use |
US8290578B2 (en) | 2007-12-28 | 2012-10-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Method and apparatus for complex impedance compensation |
US9204927B2 (en) | 2009-05-13 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | System and method for presenting information representative of lesion formation in tissue during an ablation procedure |
US8469952B2 (en) * | 2008-01-23 | 2013-06-25 | Avedro, Inc. | System and method for positioning an eye therapy device |
US8870867B2 (en) | 2008-02-06 | 2014-10-28 | Aesculap Ag | Articulable electrosurgical instrument with a stabilizable articulation actuator |
EP2265196B9 (en) | 2008-03-31 | 2013-10-02 | Applied Medical Resources Corporation | Electrosurgical system with means for measuring permittivity and conductivity of tissue |
US20090299364A1 (en) * | 2008-04-21 | 2009-12-03 | Medtronic, Inc. | Suction Force Ablation Device |
US9474574B2 (en) | 2008-05-21 | 2016-10-25 | Atricure, Inc. | Stabilized ablation systems and methods |
US9155588B2 (en) * | 2008-06-13 | 2015-10-13 | Vytronus, Inc. | System and method for positioning an elongate member with respect to an anatomical structure |
DE102008032500A1 (en) * | 2008-07-05 | 2010-01-14 | Osypka, Peter, Dr. Ing. | Medical catheter with multiple poles or electrodes |
US7752768B2 (en) * | 2008-07-23 | 2010-07-13 | Bodyaesthetic Research Center, Inc. | Marker template for breast reduction surgery |
WO2010056848A1 (en) * | 2008-11-11 | 2010-05-20 | Avedro, Inc. | Eye therapy system |
US8986291B2 (en) * | 2008-12-01 | 2015-03-24 | Percutaneous Systems, Inc. | Methods and systems for capturing and removing urinary stones from body cavities |
US9320565B2 (en) * | 2008-12-31 | 2016-04-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation devices, systems and method for measuring cooling effect of fluid flow |
US9393023B2 (en) | 2009-01-13 | 2016-07-19 | Atricure, Inc. | Apparatus and methods for deploying a clip to occlude an anatomical structure |
WO2010093603A1 (en) | 2009-02-11 | 2010-08-19 | Boston Scientific Scimed, Inc. | Insulated ablation catheter devices and methods of use |
US20100256626A1 (en) * | 2009-04-02 | 2010-10-07 | Avedro, Inc. | Eye therapy system |
WO2010115121A1 (en) | 2009-04-02 | 2010-10-07 | Avedro, Inc. | Eye therapy system |
US9642534B2 (en) | 2009-09-11 | 2017-05-09 | University Of Virginia Patent Foundation | Systems and methods for determining location of an access needle in a subject |
BR112012003356B1 (en) | 2010-02-04 | 2021-02-02 | Aesculap Ag | electrosurgical device |
CA2790328C (en) | 2010-02-18 | 2017-04-18 | University Of Virginia Patent Foundation | System, method, and computer program product for simulating epicardial electrophysiology procedures |
US8419727B2 (en) | 2010-03-26 | 2013-04-16 | Aesculap Ag | Impedance mediated power delivery for electrosurgery |
US8827992B2 (en) | 2010-03-26 | 2014-09-09 | Aesculap Ag | Impedance mediated control of power delivery for electrosurgery |
JP5670572B2 (en) * | 2010-08-31 | 2015-02-18 | クック メディカル テクノロジーズ エルエルシーCook Medical Technologies Llc | Cautery overtube |
US9173698B2 (en) | 2010-09-17 | 2015-11-03 | Aesculap Ag | Electrosurgical tissue sealing augmented with a seal-enhancing composition |
EP2621389B1 (en) | 2010-10-01 | 2015-03-18 | Applied Medical Resources Corporation | Electrosurgical instrument with jaws and with an electrode |
US9675328B2 (en) * | 2010-10-22 | 2017-06-13 | Carefusion 2200, Inc. | Catheter patch applicator assembly |
WO2012065177A2 (en) * | 2010-11-12 | 2012-05-18 | Estech, Inc (Endoscopic Technologies, Inc) | Stabilized ablation systems and methods |
US9072518B2 (en) | 2011-05-31 | 2015-07-07 | Atricure, Inc. | High-voltage pulse ablation systems and methods |
US9339327B2 (en) | 2011-06-28 | 2016-05-17 | Aesculap Ag | Electrosurgical tissue dissecting device |
WO2013166292A1 (en) * | 2012-05-02 | 2013-11-07 | The Charlotte-Mecklenburg Hospital Authority D/ B/ A Carolinas Healthcare System | Devices, systems, and methods for treating cardiac arrhythmias |
KR102174907B1 (en) | 2012-09-26 | 2020-11-05 | 아에스쿨랍 아게 | Apparatus for tissue cutting and sealing |
JP5785214B2 (en) * | 2013-05-08 | 2015-09-24 | 富士フイルム株式会社 | Mold, surgical support set, surgical support device, surgical support method, and surgical support program |
US10285750B2 (en) * | 2013-07-29 | 2019-05-14 | Covidien Lp | Systems and methods for operating an electrosurgical generator |
US10258408B2 (en) * | 2013-10-31 | 2019-04-16 | Sentreheart, Inc. | Devices and methods for left atrial appendage closure |
AU2015258819B2 (en) | 2014-05-16 | 2019-12-12 | Applied Medical Resources Corporation | Electrosurgical system |
EP3369392A1 (en) | 2014-05-30 | 2018-09-05 | Applied Medical Resources Corporation | Electrosurgical seal and dissection systems |
CN106793968A (en) | 2014-10-13 | 2017-05-31 | 波士顿科学医学有限公司 | Organizational diagnosis and treatment using microelectrode |
US10420603B2 (en) | 2014-12-23 | 2019-09-24 | Applied Medical Resources Corporation | Bipolar electrosurgical sealer and divider |
USD748259S1 (en) | 2014-12-29 | 2016-01-26 | Applied Medical Resources Corporation | Electrosurgical instrument |
WO2016176567A1 (en) | 2015-04-29 | 2016-11-03 | Innoblative Designs, Inc. | Cavitary tissue ablation |
WO2017075366A1 (en) | 2015-10-29 | 2017-05-04 | Innoblative Designs, Inc. | Screen sphere tissue ablation devices and methods |
JP6667180B2 (en) * | 2016-01-07 | 2020-03-18 | 学校法人杏林学園 | Infrared denaturing equipment |
EP3410972B1 (en) | 2016-02-02 | 2021-03-10 | Innoblative Designs, Inc. | Cavitary tissue ablation system |
US11241166B1 (en) * | 2016-02-03 | 2022-02-08 | Verily Life Sciences, LLC | Communications between smart contact lens and ingestible smart pill |
WO2017151431A1 (en) | 2016-03-01 | 2017-09-08 | Innoblative Designs, Inc. | Resecting and coagulating tissue |
WO2018075389A1 (en) | 2016-10-17 | 2018-04-26 | Innoblative Designs, Inc. | Treatment devices and methods |
EP3538000A4 (en) | 2016-11-08 | 2020-04-01 | Innoblative Designs, Inc. | Electrosurgical tissue and vessel sealing device |
US10576263B2 (en) | 2017-04-03 | 2020-03-03 | Biosense Webster (Israel) Ltd. | Tissue conduction velocity |
US11510576B2 (en) | 2017-04-27 | 2022-11-29 | Medtronic Cryocath Lp | Treatment device having multifunctional sensing elements and method of use |
US20180353664A1 (en) * | 2017-06-07 | 2018-12-13 | Innoblative Designs, Inc. | Suction collar for electrosurgical devices |
WO2019023328A1 (en) | 2017-07-26 | 2019-01-31 | Innoblative Designs, Inc. | Minimally invasive articulating assembly having ablation capabilities |
US11864812B2 (en) | 2018-09-05 | 2024-01-09 | Applied Medical Resources Corporation | Electrosurgical generator control system |
KR20210092263A (en) | 2018-11-16 | 2021-07-23 | 어플라이드 메디컬 리소시스 코포레이션 | electrosurgical system |
WO2022148155A1 (en) * | 2021-01-08 | 2022-07-14 | 北京迈迪顶峰医疗科技股份有限公司 | Electrode assembly, ablation apparatus, and radiofrequency ablation device |
Citations (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2372A (en) * | 1841-11-25 | Machine foe | ||
US41827A (en) * | 1864-03-08 | Improvement in locks | ||
US931961A (en) * | 1908-12-28 | 1909-08-24 | Frank N Robinson | Revolving stand. |
US3534733A (en) * | 1968-01-10 | 1970-10-20 | Us Navy | Spring-loaded suction cup-type biomedical instrumentation electrode |
US3542022A (en) * | 1968-02-28 | 1970-11-24 | Richard W Bartnik | Template guide for medication injection into gluteus medius muscle area |
US3590815A (en) * | 1969-01-07 | 1971-07-06 | Peter Shiff | Portable mechanical ventricular assistance device |
US3608540A (en) * | 1969-02-24 | 1971-09-28 | St Croix Research Co | Method and apparatus for aiding in the detection of breast cancer |
US3613672A (en) * | 1969-07-09 | 1971-10-19 | Peter Schiff | Mechanical ventricular assistance cup |
US3640270A (en) * | 1969-08-02 | 1972-02-08 | Niess Elektromed Ingeborg | Electric contactor with venturi-suction means for organic tissue |
US3786801A (en) * | 1969-02-24 | 1974-01-22 | Diagnostic Inc | Method and apparatus for aiding in the detection of breast cancer |
US3811443A (en) * | 1971-01-22 | 1974-05-21 | Agrophysic Inc | Method and apparatus for artificial insemination |
US3952737A (en) * | 1974-08-28 | 1976-04-27 | The Medevice Company | Contraceptive |
US4543949A (en) * | 1979-12-31 | 1985-10-01 | University Patents, Inc. | Custom valved cervical cap |
US4596566A (en) * | 1984-10-26 | 1986-06-24 | Kay Dennis M | Ostomy appliance with suction securing chamber |
US4732148A (en) * | 1983-11-17 | 1988-03-22 | Lri L.P. | Method for performing ophthalmic laser surgery |
US4736749A (en) * | 1985-04-26 | 1988-04-12 | Astra-Tech Aktiebolag | Holder for medical use fixed by vacuum |
US4973300A (en) * | 1989-09-22 | 1990-11-27 | Pioneering Technologies, Inc. | Cardiac sling for circumflex coronary artery surgery |
US4991574A (en) * | 1987-07-22 | 1991-02-12 | Dow Corning Corporation | Surgical dressing |
US5111832A (en) * | 1990-07-24 | 1992-05-12 | Sanjeev Saksena | Processes for the control of tachyarrhythmias by in vivo laser ablation of human heart tissue |
US5119804A (en) * | 1990-11-19 | 1992-06-09 | Anstadt George L | Heart massage apparatus |
US5226908A (en) * | 1989-12-05 | 1993-07-13 | Inbae Yoon | Multi-functional instruments and stretchable ligating and occluding devices |
US5248304A (en) * | 1992-05-29 | 1993-09-28 | Michael Vigdorchik | Single use intrauterine injector |
US5259836A (en) * | 1987-11-30 | 1993-11-09 | Cook Group, Incorporated | Hysterography device and method |
US5282785A (en) * | 1990-06-15 | 1994-02-01 | Cortrak Medical, Inc. | Drug delivery apparatus and method |
US5336252A (en) * | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
US5341807A (en) * | 1992-06-30 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Ablation catheter positioning system |
US5403312A (en) * | 1993-07-22 | 1995-04-04 | Ethicon, Inc. | Electrosurgical hemostatic device |
US5409000A (en) * | 1993-09-14 | 1995-04-25 | Cardiac Pathways Corporation | Endocardial mapping and ablation system utilizing separately controlled steerable ablation catheter with ultrasonic imaging capabilities and method |
US5409008A (en) * | 1991-01-30 | 1995-04-25 | Angeion Corporation | Process and apparatus for mapping of tachyarrhythmia |
US5423878A (en) * | 1984-03-06 | 1995-06-13 | Ep Technologies, Inc. | Catheter and associated system for pacing the heart |
US5437658A (en) * | 1992-10-07 | 1995-08-01 | Summit Technology, Incorporated | Method and system for laser thermokeratoplasty of the cornea |
US5447529A (en) * | 1994-01-28 | 1995-09-05 | Philadelphia Heart Institute | Method of using endocardial impedance for determining electrode-tissue contact, appropriate sites for arrhythmia ablation and tissue heating during ablation |
US5484407A (en) * | 1993-06-24 | 1996-01-16 | Osypka; Peter | Catheter with steerable distal end |
US5497771A (en) * | 1993-04-02 | 1996-03-12 | Mipm Mammendorfer Institut Fuer Physik Und Medizin Gmbh | Apparatus for measuring the oxygen saturation of fetuses during childbirth |
US5499971A (en) * | 1990-06-15 | 1996-03-19 | Cortrak Medical, Inc. | Method for iontophoretically delivering drug adjacent to a heart |
US5509890A (en) * | 1993-12-16 | 1996-04-23 | Kazama; Shigeru | Heart retractor |
US5536243A (en) * | 1994-12-13 | 1996-07-16 | Jeyendran; Rajasingam S. | Time-release insemination device |
US5545123A (en) * | 1994-03-15 | 1996-08-13 | Ethicon, Inc. | Surgical lift method and apparatus |
US5553612A (en) * | 1992-02-20 | 1996-09-10 | Humanteknik Ab | Device for securing an object to a surface by vacuum |
US5562658A (en) * | 1994-03-25 | 1996-10-08 | Snj Company, Inc. | Laser-powered surgical device for making incisions of selected depth |
US5575810A (en) * | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5651378A (en) * | 1996-02-20 | 1997-07-29 | Cardiothoracic Systems, Inc. | Method of using vagal nerve stimulation in surgery |
US5665105A (en) * | 1996-03-20 | 1997-09-09 | Snowden Pencer/Genzyme Corporation | Radially adjustable surgical instrument for heart surgery |
US5676662A (en) * | 1995-03-17 | 1997-10-14 | Daig Corporation | Ablation catheter |
US5725521A (en) * | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US5727569A (en) * | 1996-02-20 | 1998-03-17 | Cardiothoracic Systems, Inc. | Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery |
US5730757A (en) * | 1996-02-20 | 1998-03-24 | Cardiothoracic Systems, Inc. | Access platform for internal mammary dissection |
US5738683A (en) * | 1994-07-16 | 1998-04-14 | Osypka; Peter | Mapping and ablation catheter |
US5762458A (en) * | 1996-02-20 | 1998-06-09 | Computer Motion, Inc. | Method and apparatus for performing minimally invasive cardiac procedures |
US5776154A (en) * | 1996-02-20 | 1998-07-07 | Cardiothoracic Systems, Inc. | Surgical instruments for making precise incisions in a cardiac vessel |
US5779661A (en) * | 1995-12-11 | 1998-07-14 | Physion, S.R.L. | Method of treating dysfunctional bladder syndromes by electromotive drug administration |
US5782823A (en) * | 1996-04-05 | 1998-07-21 | Eclipse Surgical Technologies, Inc. | Laser device for transmyocardial revascularization procedures including means for enabling a formation of a pilot hole in the epicardium |
US5782746A (en) * | 1996-02-15 | 1998-07-21 | Wright; John T. M. | Local cardiac immobilization surgical device |
US5799661A (en) * | 1993-02-22 | 1998-09-01 | Heartport, Inc. | Devices and methods for port-access multivessel coronary artery bypass surgery |
US5807388A (en) * | 1994-05-25 | 1998-09-15 | The Trustees Of Columbia University In The City Of New York | Myocardial revascularization through the endocardial surface using a laser |
US5807243A (en) * | 1994-08-31 | 1998-09-15 | Heartport, Inc. | Method for isolating a surgical site |
US5810721A (en) * | 1996-03-04 | 1998-09-22 | Heartport, Inc. | Soft tissue retractor and method for providing surgical access |
US5836311A (en) * | 1995-09-20 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
US5855583A (en) * | 1996-02-20 | 1999-01-05 | Computer Motion, Inc. | Method and apparatus for performing minimally invasive cardiac procedures |
US5865730A (en) * | 1997-10-07 | 1999-02-02 | Ethicon Endo-Surgery, Inc. | Tissue stabilization device for use during surgery having remotely actuated feet |
US5868763A (en) * | 1996-09-16 | 1999-02-09 | Guidant Corporation | Means and methods for performing an anastomosis |
US5871017A (en) * | 1996-10-15 | 1999-02-16 | Mayer; Paul W. | Relative motion cancelling platform for surgery |
US5871495A (en) * | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US5876340A (en) * | 1997-04-17 | 1999-03-02 | Irvine Biomedical, Inc. | Ablation apparatus with ultrasonic imaging capabilities |
US5875782A (en) * | 1996-11-14 | 1999-03-02 | Cardiothoracic Systems, Inc. | Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass |
US5885271A (en) * | 1997-03-14 | 1999-03-23 | Millennium Cardiac Strategies, Inc. | Device for regional immobilization of a compliant body |
US5888247A (en) * | 1995-04-10 | 1999-03-30 | Cardiothoracic Systems, Inc | Method for coronary artery bypass |
US5891017A (en) * | 1997-01-31 | 1999-04-06 | Baxter Research Medical, Inc. | Surgical stabilizer and method for isolating and immobilizing cardiac tissue |
US5893848A (en) * | 1996-10-24 | 1999-04-13 | Plc Medical Systems, Inc. | Gauging system for monitoring channel depth in percutaneous endocardial revascularization |
US5894843A (en) * | 1996-02-20 | 1999-04-20 | Cardiothoracic Systems, Inc. | Surgical method for stabilizing the beating heart during coronary artery bypass graft surgery |
US5899425A (en) * | 1997-05-02 | 1999-05-04 | Medtronic, Inc. | Adjustable supporting bracket having plural ball and socket joints |
US5910150A (en) * | 1996-12-02 | 1999-06-08 | Angiotrax, Inc. | Apparatus for performing surgery |
US5913876A (en) * | 1996-02-20 | 1999-06-22 | Cardiothoracic Systems, Inc. | Method and apparatus for using vagus nerve stimulation in surgery |
US5916213A (en) * | 1997-02-04 | 1999-06-29 | Medtronic, Inc. | Systems and methods for tissue mapping and ablation |
US5935141A (en) * | 1997-10-30 | 1999-08-10 | Partisan Management Group | Interventional cardiology instrument controlled from an intracoronary reference |
US5938660A (en) * | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US5944730A (en) * | 1997-05-19 | 1999-08-31 | Cardio Medical Solutions, Inc. | Device and method for assisting end-to-side anastomosis |
US5944736A (en) * | 1996-02-20 | 1999-08-31 | Cardiothoracic Systems, Inc. | Access platform for internal mammary dissection |
US5947835A (en) * | 1998-06-30 | 1999-09-07 | Fenton, Jr.; Francis A. | Golf swing exercise and training device |
US5964754A (en) * | 1996-05-24 | 1999-10-12 | Sulzer Osypka Gmbh | Device for perforating the heart wall |
US5971980A (en) * | 1995-05-02 | 1999-10-26 | Heart Rhythm Technologies, Inc. | System for controlling the energy delivered to a patient for ablation |
US5972020A (en) * | 1997-02-14 | 1999-10-26 | Cardiothoracic Systems, Inc. | Surgical instrument for cardiac valve repair on the beating heart |
US5971976A (en) * | 1996-02-20 | 1999-10-26 | Computer Motion, Inc. | Motion minimization and compensation system for use in surgical procedures |
US5976164A (en) * | 1996-09-13 | 1999-11-02 | Eclipse Surgical Technologies, Inc. | Method and apparatus for myocardial revascularization and/or biopsy of the heart |
US5978695A (en) * | 1997-08-18 | 1999-11-02 | Lucid Inc. | System for imaging mechanically stabilized tissue |
US5976069A (en) * | 1996-07-25 | 1999-11-02 | Guidant Corporation | Epicardial immobilization device |
US6014579A (en) * | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
US6088614A (en) * | 1997-03-31 | 2000-07-11 | Boston Scientific Corporation | Tissue characterization to identify an ablation site |
US6183468B1 (en) * | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6237605B1 (en) * | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US6302880B1 (en) * | 1996-04-08 | 2001-10-16 | Cardima, Inc. | Linear ablation assembly |
US6423057B1 (en) * | 1999-01-25 | 2002-07-23 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method and apparatus for monitoring and controlling tissue temperature and lesion formation in radio-frequency ablation procedures |
US6514250B1 (en) * | 2000-04-27 | 2003-02-04 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3926192A (en) | 1974-08-12 | 1975-12-16 | Maren Harold B Van | Atraumatic uterine director |
US4048990A (en) | 1976-09-17 | 1977-09-20 | Goetz Robert H | Heart massage apparatus |
US4362157A (en) | 1981-02-18 | 1982-12-07 | Keeth John D | Template for locating hypodermic injection sites |
US5507741A (en) | 1983-11-17 | 1996-04-16 | L'esperance, Jr.; Francis A. | Ophthalmic method for laser surgery of the cornea |
DE3465697D1 (en) | 1984-03-23 | 1987-10-08 | Karl Storz | Single hand operated hysteroscope |
AU2567188A (en) | 1987-11-30 | 1989-06-01 | Milos Sovak | Hysterography device |
IT1251542B (en) | 1991-03-06 | 1995-05-17 | D D S R L | DEVICE FOR THERAPEUTIC OR HYGIENE WASHING OF INTERNAL HUMAN OR ANIMAL BODIES, WHICH ALLOWS THE DRAINAGE OF WASHING LIQUID |
US5843019A (en) | 1992-01-07 | 1998-12-01 | Arthrocare Corporation | Shaped electrodes and methods for electrosurgical cutting and ablation |
US5472438A (en) | 1993-07-22 | 1995-12-05 | Case Western Reserve University | Laproscopic vacuum delivery apparatus for a diaphragm daper |
US6146379A (en) * | 1993-10-15 | 2000-11-14 | Ep Technologies, Inc. | Systems and methods for creating curvilinear lesions in body tissue |
WO1995020344A1 (en) * | 1994-01-28 | 1995-08-03 | Ep Technologies, Inc. | System for examining cardiac tissue electrical characteristics |
US6322558B1 (en) | 1995-06-09 | 2001-11-27 | Engineering & Research Associates, Inc. | Apparatus and method for predicting ablation depth |
US6290644B1 (en) | 1996-02-20 | 2001-09-18 | Cardiothoracic Systems, Inc. | Surgical instruments and procedures for stabilizing a localized portion of a beating heart |
CA2197614C (en) | 1996-02-20 | 2002-07-02 | Charles S. Taylor | Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery |
US5871496A (en) | 1996-03-20 | 1999-02-16 | Cardiothoracic Systems, Inc. | Surgical instrument for facilitating the detachment of an artery and the like |
US5947896A (en) | 1996-04-26 | 1999-09-07 | United States Surgical Corporation | Heart stabilizer apparatus and method for use |
US6066139A (en) * | 1996-05-14 | 2000-05-23 | Sherwood Services Ag | Apparatus and method for sterilization and embolization |
US5976123A (en) | 1996-07-30 | 1999-11-02 | Laser Aesthetics, Inc. | Heart stabilization |
EP0823263A1 (en) | 1996-08-06 | 1998-02-11 | Dr.-Ing. P. Osypka GmbH | Connecting element for the external tip of a surgical electrode |
US5976080A (en) | 1996-09-20 | 1999-11-02 | United States Surgical | Surgical apparatus and method |
EP0832602B1 (en) | 1996-09-27 | 2004-03-17 | Sulzer Osypka GmbH | Device for carrying out diagnostic and/or therapeutic heart procedures with a catheter |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US5899915A (en) | 1996-12-02 | 1999-05-04 | Angiotrax, Inc. | Apparatus and method for intraoperatively performing surgery |
US5921979A (en) | 1996-12-18 | 1999-07-13 | Guidant Corporation | Apparatus and method for tissue and organ stabilization |
US5843020A (en) | 1997-04-16 | 1998-12-01 | Irvine Biomedical, Inc. | Ablation device and methods |
US6012457A (en) | 1997-07-08 | 2000-01-11 | The Regents Of The University Of California | Device and method for forming a circumferential conduction block in a pulmonary vein |
US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
US5957835A (en) | 1997-05-16 | 1999-09-28 | Guidant Corporation | Apparatus and method for cardiac stabilization and arterial occlusion |
US6015427A (en) | 1997-07-07 | 2000-01-18 | Eclipse Surgical Technologies, Inc. | Heart stabilizer with controllable stay suture and cutting element |
US6338712B2 (en) | 1997-09-17 | 2002-01-15 | Origin Medsystems, Inc. | Device to permit offpump beating heart coronary bypass surgery |
US6019722A (en) | 1997-09-17 | 2000-02-01 | Guidant Corporation | Device to permit offpump beating heart coronary bypass surgery |
US6139538A (en) | 1997-10-06 | 2000-10-31 | Iotek, Inc. | Iontophoretic agent delivery to the female reproductive tract |
US6007486A (en) | 1997-10-07 | 1999-12-28 | Ethicon Endo-Surgery, Inc. | Tissue stabilization device for use during surgery having a segmented shaft |
US5984864A (en) | 1997-10-07 | 1999-11-16 | Ethicon Endo-Surgery, Inc. | Tissue stabilization device for use during surgery |
US6013027A (en) | 1997-10-07 | 2000-01-11 | Ethicon Endo-Surgery, Inc. | Method for using a tissue stabilization device during surgery |
US6231585B1 (en) | 1997-11-20 | 2001-05-15 | Medivas, Llc | Device for stabilizing a treatment site and method of use |
MXPA01002686A (en) | 1998-09-15 | 2002-06-04 | Medtronic Inc | Method and apparatus for temporarily immobilizing a local area of tissue. |
US6007523A (en) | 1998-09-28 | 1999-12-28 | Embol-X, Inc. | Suction support and method of use |
US6290699B1 (en) | 1999-07-07 | 2001-09-18 | Uab Research Foundation | Ablation tool for forming lesions in body tissue |
US6332881B1 (en) | 1999-09-01 | 2001-12-25 | Cardima, Inc. | Surgical ablation tool |
US6506149B2 (en) | 1999-09-07 | 2003-01-14 | Origin Medsystems, Inc. | Organ manipulator having suction member supported with freedom to move relative to its support |
US6546935B2 (en) | 2000-04-27 | 2003-04-15 | Atricure, Inc. | Method for transmural ablation |
US6558382B2 (en) | 2000-04-27 | 2003-05-06 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
-
2000
- 2000-08-28 US US09/649,998 patent/US6663622B1/en not_active Expired - Fee Related
-
2001
- 2001-02-09 WO PCT/US2001/004235 patent/WO2001058373A1/en not_active Application Discontinuation
- 2001-02-09 AU AU2001236831A patent/AU2001236831A1/en not_active Abandoned
- 2001-02-09 EP EP01909035A patent/EP1253867A1/en not_active Withdrawn
- 2001-02-09 CA CA002397370A patent/CA2397370A1/en not_active Abandoned
-
2002
- 2002-05-28 US US10/158,435 patent/US20020143326A1/en not_active Abandoned
-
2003
- 2003-11-07 US US10/704,419 patent/US20040073206A1/en not_active Abandoned
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US41827A (en) * | 1864-03-08 | Improvement in locks | ||
US2372A (en) * | 1841-11-25 | Machine foe | ||
US931961A (en) * | 1908-12-28 | 1909-08-24 | Frank N Robinson | Revolving stand. |
US3534733A (en) * | 1968-01-10 | 1970-10-20 | Us Navy | Spring-loaded suction cup-type biomedical instrumentation electrode |
US3542022A (en) * | 1968-02-28 | 1970-11-24 | Richard W Bartnik | Template guide for medication injection into gluteus medius muscle area |
US3590815A (en) * | 1969-01-07 | 1971-07-06 | Peter Shiff | Portable mechanical ventricular assistance device |
US3786801A (en) * | 1969-02-24 | 1974-01-22 | Diagnostic Inc | Method and apparatus for aiding in the detection of breast cancer |
US3608540A (en) * | 1969-02-24 | 1971-09-28 | St Croix Research Co | Method and apparatus for aiding in the detection of breast cancer |
US3613672A (en) * | 1969-07-09 | 1971-10-19 | Peter Schiff | Mechanical ventricular assistance cup |
US3640270A (en) * | 1969-08-02 | 1972-02-08 | Niess Elektromed Ingeborg | Electric contactor with venturi-suction means for organic tissue |
US3811443A (en) * | 1971-01-22 | 1974-05-21 | Agrophysic Inc | Method and apparatus for artificial insemination |
US3952737A (en) * | 1974-08-28 | 1976-04-27 | The Medevice Company | Contraceptive |
US4543949A (en) * | 1979-12-31 | 1985-10-01 | University Patents, Inc. | Custom valved cervical cap |
US4732148A (en) * | 1983-11-17 | 1988-03-22 | Lri L.P. | Method for performing ophthalmic laser surgery |
US5423878A (en) * | 1984-03-06 | 1995-06-13 | Ep Technologies, Inc. | Catheter and associated system for pacing the heart |
US4596566A (en) * | 1984-10-26 | 1986-06-24 | Kay Dennis M | Ostomy appliance with suction securing chamber |
US4736749A (en) * | 1985-04-26 | 1988-04-12 | Astra-Tech Aktiebolag | Holder for medical use fixed by vacuum |
US4991574A (en) * | 1987-07-22 | 1991-02-12 | Dow Corning Corporation | Surgical dressing |
US5259836A (en) * | 1987-11-30 | 1993-11-09 | Cook Group, Incorporated | Hysterography device and method |
US4973300A (en) * | 1989-09-22 | 1990-11-27 | Pioneering Technologies, Inc. | Cardiac sling for circumflex coronary artery surgery |
US5226908A (en) * | 1989-12-05 | 1993-07-13 | Inbae Yoon | Multi-functional instruments and stretchable ligating and occluding devices |
US5499971A (en) * | 1990-06-15 | 1996-03-19 | Cortrak Medical, Inc. | Method for iontophoretically delivering drug adjacent to a heart |
US5282785A (en) * | 1990-06-15 | 1994-02-01 | Cortrak Medical, Inc. | Drug delivery apparatus and method |
US5111832A (en) * | 1990-07-24 | 1992-05-12 | Sanjeev Saksena | Processes for the control of tachyarrhythmias by in vivo laser ablation of human heart tissue |
US5119804A (en) * | 1990-11-19 | 1992-06-09 | Anstadt George L | Heart massage apparatus |
US5409008A (en) * | 1991-01-30 | 1995-04-25 | Angeion Corporation | Process and apparatus for mapping of tachyarrhythmia |
US5553612A (en) * | 1992-02-20 | 1996-09-10 | Humanteknik Ab | Device for securing an object to a surface by vacuum |
US5248304A (en) * | 1992-05-29 | 1993-09-28 | Michael Vigdorchik | Single use intrauterine injector |
US5336252A (en) * | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
US5341807A (en) * | 1992-06-30 | 1994-08-30 | American Cardiac Ablation Co., Inc. | Ablation catheter positioning system |
US5437658A (en) * | 1992-10-07 | 1995-08-01 | Summit Technology, Incorporated | Method and system for laser thermokeratoplasty of the cornea |
US5799661A (en) * | 1993-02-22 | 1998-09-01 | Heartport, Inc. | Devices and methods for port-access multivessel coronary artery bypass surgery |
US5497771A (en) * | 1993-04-02 | 1996-03-12 | Mipm Mammendorfer Institut Fuer Physik Und Medizin Gmbh | Apparatus for measuring the oxygen saturation of fetuses during childbirth |
US5484407A (en) * | 1993-06-24 | 1996-01-16 | Osypka; Peter | Catheter with steerable distal end |
US5403312A (en) * | 1993-07-22 | 1995-04-04 | Ethicon, Inc. | Electrosurgical hemostatic device |
US5409000A (en) * | 1993-09-14 | 1995-04-25 | Cardiac Pathways Corporation | Endocardial mapping and ablation system utilizing separately controlled steerable ablation catheter with ultrasonic imaging capabilities and method |
US5575810A (en) * | 1993-10-15 | 1996-11-19 | Ep Technologies, Inc. | Composite structures and methods for ablating tissue to form complex lesion patterns in the treatment of cardiac conditions and the like |
US5509890A (en) * | 1993-12-16 | 1996-04-23 | Kazama; Shigeru | Heart retractor |
US5562721A (en) * | 1994-01-28 | 1996-10-08 | University Of Pennsylvania | Method of using endocardial impedance for assessing tissue heating during ablation |
US5447529A (en) * | 1994-01-28 | 1995-09-05 | Philadelphia Heart Institute | Method of using endocardial impedance for determining electrode-tissue contact, appropriate sites for arrhythmia ablation and tissue heating during ablation |
US5545123A (en) * | 1994-03-15 | 1996-08-13 | Ethicon, Inc. | Surgical lift method and apparatus |
US5562658A (en) * | 1994-03-25 | 1996-10-08 | Snj Company, Inc. | Laser-powered surgical device for making incisions of selected depth |
US5807388A (en) * | 1994-05-25 | 1998-09-15 | The Trustees Of Columbia University In The City Of New York | Myocardial revascularization through the endocardial surface using a laser |
US5593405A (en) * | 1994-07-16 | 1997-01-14 | Osypka; Peter | Fiber optic endoscope |
US5738683A (en) * | 1994-07-16 | 1998-04-14 | Osypka; Peter | Mapping and ablation catheter |
US5807243A (en) * | 1994-08-31 | 1998-09-15 | Heartport, Inc. | Method for isolating a surgical site |
US5536243A (en) * | 1994-12-13 | 1996-07-16 | Jeyendran; Rajasingam S. | Time-release insemination device |
US5676662A (en) * | 1995-03-17 | 1997-10-14 | Daig Corporation | Ablation catheter |
US5888247A (en) * | 1995-04-10 | 1999-03-30 | Cardiothoracic Systems, Inc | Method for coronary artery bypass |
US5971980A (en) * | 1995-05-02 | 1999-10-26 | Heart Rhythm Technologies, Inc. | System for controlling the energy delivered to a patient for ablation |
US5836311A (en) * | 1995-09-20 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
US5927284A (en) * | 1995-09-20 | 1999-07-27 | Medtronic, Inc | Method and apparatus for temporarily immobilizing a local area of tissue |
US5779661A (en) * | 1995-12-11 | 1998-07-14 | Physion, S.R.L. | Method of treating dysfunctional bladder syndromes by electromotive drug administration |
US5782746A (en) * | 1996-02-15 | 1998-07-21 | Wright; John T. M. | Local cardiac immobilization surgical device |
US5727569A (en) * | 1996-02-20 | 1998-03-17 | Cardiothoracic Systems, Inc. | Surgical devices for imposing a negative pressure to fix the position of cardiac tissue during surgery |
US5894843A (en) * | 1996-02-20 | 1999-04-20 | Cardiothoracic Systems, Inc. | Surgical method for stabilizing the beating heart during coronary artery bypass graft surgery |
US5776154A (en) * | 1996-02-20 | 1998-07-07 | Cardiothoracic Systems, Inc. | Surgical instruments for making precise incisions in a cardiac vessel |
US5762458A (en) * | 1996-02-20 | 1998-06-09 | Computer Motion, Inc. | Method and apparatus for performing minimally invasive cardiac procedures |
US5730757A (en) * | 1996-02-20 | 1998-03-24 | Cardiothoracic Systems, Inc. | Access platform for internal mammary dissection |
US5855583A (en) * | 1996-02-20 | 1999-01-05 | Computer Motion, Inc. | Method and apparatus for performing minimally invasive cardiac procedures |
US5971976A (en) * | 1996-02-20 | 1999-10-26 | Computer Motion, Inc. | Motion minimization and compensation system for use in surgical procedures |
US5651378A (en) * | 1996-02-20 | 1997-07-29 | Cardiothoracic Systems, Inc. | Method of using vagal nerve stimulation in surgery |
US5944736A (en) * | 1996-02-20 | 1999-08-31 | Cardiothoracic Systems, Inc. | Access platform for internal mammary dissection |
US5913876A (en) * | 1996-02-20 | 1999-06-22 | Cardiothoracic Systems, Inc. | Method and apparatus for using vagus nerve stimulation in surgery |
US5906607A (en) * | 1996-02-20 | 1999-05-25 | Cardiothoracic Systems, Inc. | Surgical devices for imposing a negative pressure to stabilize cardiac tissue during surgery |
US5810721A (en) * | 1996-03-04 | 1998-09-22 | Heartport, Inc. | Soft tissue retractor and method for providing surgical access |
US5665105A (en) * | 1996-03-20 | 1997-09-09 | Snowden Pencer/Genzyme Corporation | Radially adjustable surgical instrument for heart surgery |
US5725521A (en) * | 1996-03-29 | 1998-03-10 | Eclipse Surgical Technologies, Inc. | Depth stop apparatus and method for laser-assisted transmyocardial revascularization and other surgical applications |
US5782823A (en) * | 1996-04-05 | 1998-07-21 | Eclipse Surgical Technologies, Inc. | Laser device for transmyocardial revascularization procedures including means for enabling a formation of a pilot hole in the epicardium |
US6302880B1 (en) * | 1996-04-08 | 2001-10-16 | Cardima, Inc. | Linear ablation assembly |
US5964754A (en) * | 1996-05-24 | 1999-10-12 | Sulzer Osypka Gmbh | Device for perforating the heart wall |
US5976069A (en) * | 1996-07-25 | 1999-11-02 | Guidant Corporation | Epicardial immobilization device |
US5871495A (en) * | 1996-09-13 | 1999-02-16 | Eclipse Surgical Technologies, Inc. | Method and apparatus for mechanical transmyocardial revascularization of the heart |
US5976164A (en) * | 1996-09-13 | 1999-11-02 | Eclipse Surgical Technologies, Inc. | Method and apparatus for myocardial revascularization and/or biopsy of the heart |
US5868763A (en) * | 1996-09-16 | 1999-02-09 | Guidant Corporation | Means and methods for performing an anastomosis |
US5871017A (en) * | 1996-10-15 | 1999-02-16 | Mayer; Paul W. | Relative motion cancelling platform for surgery |
US6237605B1 (en) * | 1996-10-22 | 2001-05-29 | Epicor, Inc. | Methods of epicardial ablation |
US5893848A (en) * | 1996-10-24 | 1999-04-13 | Plc Medical Systems, Inc. | Gauging system for monitoring channel depth in percutaneous endocardial revascularization |
US5875782A (en) * | 1996-11-14 | 1999-03-02 | Cardiothoracic Systems, Inc. | Methods and devices for minimally invasive coronary artery revascularization on a beating heart without cardiopulmonary bypass |
US5910150A (en) * | 1996-12-02 | 1999-06-08 | Angiotrax, Inc. | Apparatus for performing surgery |
US5941893A (en) * | 1996-12-02 | 1999-08-24 | Angiotrax, Inc. | Apparatus for transluminally performing surgery |
US5931848A (en) * | 1996-12-02 | 1999-08-03 | Angiotrax, Inc. | Methods for transluminally performing surgery |
US5891017A (en) * | 1997-01-31 | 1999-04-06 | Baxter Research Medical, Inc. | Surgical stabilizer and method for isolating and immobilizing cardiac tissue |
US5916213A (en) * | 1997-02-04 | 1999-06-29 | Medtronic, Inc. | Systems and methods for tissue mapping and ablation |
US5972020A (en) * | 1997-02-14 | 1999-10-26 | Cardiothoracic Systems, Inc. | Surgical instrument for cardiac valve repair on the beating heart |
US5885271A (en) * | 1997-03-14 | 1999-03-23 | Millennium Cardiac Strategies, Inc. | Device for regional immobilization of a compliant body |
US6088614A (en) * | 1997-03-31 | 2000-07-11 | Boston Scientific Corporation | Tissue characterization to identify an ablation site |
US5876340A (en) * | 1997-04-17 | 1999-03-02 | Irvine Biomedical, Inc. | Ablation apparatus with ultrasonic imaging capabilities |
US5899425A (en) * | 1997-05-02 | 1999-05-04 | Medtronic, Inc. | Adjustable supporting bracket having plural ball and socket joints |
US5944730A (en) * | 1997-05-19 | 1999-08-31 | Cardio Medical Solutions, Inc. | Device and method for assisting end-to-side anastomosis |
US5938660A (en) * | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US6014579A (en) * | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
US5978695A (en) * | 1997-08-18 | 1999-11-02 | Lucid Inc. | System for imaging mechanically stabilized tissue |
US5865730A (en) * | 1997-10-07 | 1999-02-02 | Ethicon Endo-Surgery, Inc. | Tissue stabilization device for use during surgery having remotely actuated feet |
US5935141A (en) * | 1997-10-30 | 1999-08-10 | Partisan Management Group | Interventional cardiology instrument controlled from an intracoronary reference |
US5947835A (en) * | 1998-06-30 | 1999-09-07 | Fenton, Jr.; Francis A. | Golf swing exercise and training device |
US6183468B1 (en) * | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
US6423057B1 (en) * | 1999-01-25 | 2002-07-23 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method and apparatus for monitoring and controlling tissue temperature and lesion formation in radio-frequency ablation procedures |
US6514250B1 (en) * | 2000-04-27 | 2003-02-04 | Medtronic, Inc. | Suction stabilized epicardial ablation devices |
Cited By (243)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10335280B2 (en) | 2000-01-19 | 2019-07-02 | Medtronic, Inc. | Method for ablating target tissue of a patient |
US20070156185A1 (en) * | 2001-12-04 | 2007-07-05 | Swanson David K | Ablative treatment of the heart to improve patient outcomes following surgery |
US20090012510A1 (en) * | 2001-12-04 | 2009-01-08 | Endoscopic Technologies, Inc. | Cardiac ablation devices and methods |
US8096990B2 (en) * | 2001-12-04 | 2012-01-17 | Endoscopic Technologies, Inc. | Ablative treatment of the heart to improve patient outcomes following surgery |
US8454593B2 (en) | 2001-12-04 | 2013-06-04 | Endoscopic Technologies, Inc. | Method for ablating heart tissue to treat a cardiac arrhythmia |
US8545498B2 (en) | 2001-12-04 | 2013-10-01 | Endoscopic Technologies, Inc. | Cardiac ablation devices and methods |
US20050148856A1 (en) * | 2002-03-22 | 2005-07-07 | Schulze Dale R. | Medical device that removably attaches to a bodily organ |
US20030181890A1 (en) * | 2002-03-22 | 2003-09-25 | Schulze Dale R. | Medical device that removably attaches to a bodily organ |
US7223239B2 (en) | 2002-03-22 | 2007-05-29 | Ethicon Endo-Surgery, Inc. | Medical device that removably attaches to a bodily organ |
US10293190B2 (en) | 2002-04-08 | 2019-05-21 | Medtronic Ardian Luxembourg S.A.R.L. | Thermally-induced renal neuromodulation and associated systems and methods |
US9827040B2 (en) | 2002-04-08 | 2017-11-28 | Medtronic Adrian Luxembourg S.a.r.l. | Methods and apparatus for intravascularly-induced neuromodulation |
US9827041B2 (en) | 2002-04-08 | 2017-11-28 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatuses for renal denervation |
US9757193B2 (en) | 2002-04-08 | 2017-09-12 | Medtronic Ardian Luxembourg S.A.R.L. | Balloon catheter apparatus for renal neuromodulation |
US10105180B2 (en) | 2002-04-08 | 2018-10-23 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravascularly-induced neuromodulation |
US10420606B2 (en) | 2002-04-08 | 2019-09-24 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US9486270B2 (en) | 2002-04-08 | 2016-11-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for bilateral renal neuromodulation |
US10376311B2 (en) | 2002-04-08 | 2019-08-13 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for intravascularly-induced neuromodulation |
US10953170B2 (en) | 2003-05-13 | 2021-03-23 | Nuvaira, Inc. | Apparatus for treating asthma using neurotoxin |
US9339618B2 (en) | 2003-05-13 | 2016-05-17 | Holaira, Inc. | Method and apparatus for controlling narrowing of at least one airway |
US7938823B2 (en) | 2003-06-10 | 2011-05-10 | Medtronic Cryocath Lp | Surgical clamp having transmurality assessment capabilities |
US7914524B2 (en) | 2003-06-10 | 2011-03-29 | Medtronic Cryocath Lp | Surgical clamp having trasmurality assessment capabilities |
US20040254606A1 (en) * | 2003-06-10 | 2004-12-16 | Dan Wittenberger | Surgical clamp having trasmurality assessment capabilities |
US7981110B2 (en) | 2003-06-10 | 2011-07-19 | Medtronic Cryocath Lp | Surgical clamp having trasmurality assessment capabilities |
US20070149962A1 (en) * | 2003-06-10 | 2007-06-28 | Dan Wittenberger | Surgical clamp having trasmurality assessment capabilities |
US7955325B2 (en) | 2003-06-10 | 2011-06-07 | Medtronic Cryocath Lp | Surgical clamp having transmurality assessment capabilities |
US7819860B2 (en) | 2003-06-10 | 2010-10-26 | Medtronic Cryocath Lp | Surgical clamp having trasmurality assessment capabilities |
US20070149960A1 (en) * | 2003-06-10 | 2007-06-28 | Cryocath Technologies Inc. | Surgical clamp having transmurality assessment capabilities |
US20070149969A1 (en) * | 2003-06-10 | 2007-06-28 | Cryocath Technologies Inc. | Surgical clamp having transmurality assessment capabilities |
US9510901B2 (en) | 2003-09-12 | 2016-12-06 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US20080161801A1 (en) * | 2003-09-12 | 2008-07-03 | Minnow Medical, Inc. | Selectable Eccentric Remodeling and/or Ablation of Atherosclerotic Material |
US9125666B2 (en) | 2003-09-12 | 2015-09-08 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation of atherosclerotic material |
US10188457B2 (en) | 2003-09-12 | 2019-01-29 | Vessix Vascular, Inc. | Selectable eccentric remodeling and/or ablation |
US7232437B2 (en) * | 2003-10-30 | 2007-06-19 | Medical Cv, Inc. | Assessment of lesion transmurality |
US20050209589A1 (en) * | 2003-10-30 | 2005-09-22 | Medical Cv, Inc. | Assessment of lesion transmurality |
US20070225558A1 (en) * | 2004-05-28 | 2007-09-27 | Hauck John A | Robotic surgical system and method for surface modeling |
US9204935B2 (en) | 2004-05-28 | 2015-12-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for diagnostic data mapping |
US20070198008A1 (en) * | 2004-05-28 | 2007-08-23 | Hauck John A | Robotic surgical system and method for automated therapy delivery |
US20070185404A1 (en) * | 2004-05-28 | 2007-08-09 | Hauck John A | Robotic surgical system and method for diagnostic data mapping |
US10258285B2 (en) | 2004-05-28 | 2019-04-16 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for automated creation of ablation lesions |
US8755864B2 (en) | 2004-05-28 | 2014-06-17 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for diagnostic data mapping |
US9566119B2 (en) | 2004-05-28 | 2017-02-14 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for automated therapy delivery |
US8551084B2 (en) | 2004-05-28 | 2013-10-08 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Radio frequency ablation servo catheter and method |
US20060015096A1 (en) * | 2004-05-28 | 2006-01-19 | Hauck John A | Radio frequency ablation servo catheter and method |
US10863945B2 (en) | 2004-05-28 | 2020-12-15 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system with contact sensing feature |
US20070181139A1 (en) * | 2004-05-28 | 2007-08-09 | Hauck John A | Robotic surgical system with contact sensing feature |
US20070185486A1 (en) * | 2004-05-28 | 2007-08-09 | Hauck John A | Robotic surgical system |
US9782130B2 (en) | 2004-05-28 | 2017-10-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system |
US7974674B2 (en) | 2004-05-28 | 2011-07-05 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for surface modeling |
US8528565B2 (en) | 2004-05-28 | 2013-09-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotic surgical system and method for automated therapy delivery |
US20070185485A1 (en) * | 2004-05-28 | 2007-08-09 | Hauck John A | Robotic surgical system and method for automated creation of ablation lesions |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US9125667B2 (en) | 2004-09-10 | 2015-09-08 | Vessix Vascular, Inc. | System for inducing desirable temperature effects on body tissue |
US8939970B2 (en) | 2004-09-10 | 2015-01-27 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US20080125772A1 (en) * | 2004-09-10 | 2008-05-29 | Minnow Medical, Inc | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US20100168743A1 (en) * | 2005-03-28 | 2010-07-01 | Minnow Medical, Inc. | Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures |
US7742795B2 (en) * | 2005-03-28 | 2010-06-22 | Minnow Medical, Inc. | Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures |
US20060235286A1 (en) * | 2005-03-28 | 2006-10-19 | Minnow Medical, Llc | Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures |
US8364237B2 (en) | 2005-03-28 | 2013-01-29 | Vessix Vascular, Inc. | Tuned RF energy for selective treatment of atheroma and other target tissues and/or structures |
US9486355B2 (en) | 2005-05-03 | 2016-11-08 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US8407023B2 (en) | 2005-05-27 | 2013-03-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotically controlled catheter and method of its calibration |
US8155910B2 (en) | 2005-05-27 | 2012-04-10 | St. Jude Medical, Atrial Fibrillation Divison, Inc. | Robotically controlled catheter and method of its calibration |
US9237930B2 (en) | 2005-05-27 | 2016-01-19 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Robotically controlled catheter and method of its calibration |
US9005229B2 (en) | 2005-09-07 | 2015-04-14 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9364246B2 (en) | 2005-09-07 | 2016-06-14 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9179928B2 (en) | 2005-09-07 | 2015-11-10 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US8518069B2 (en) | 2005-09-07 | 2013-08-27 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9011473B2 (en) | 2005-09-07 | 2015-04-21 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US20100228182A1 (en) * | 2005-09-07 | 2010-09-09 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9358033B2 (en) | 2005-09-07 | 2016-06-07 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
US9486274B2 (en) | 2005-09-07 | 2016-11-08 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9248317B2 (en) | 2005-12-02 | 2016-02-02 | Ulthera, Inc. | Devices and methods for selectively lysing cells |
US9272124B2 (en) | 2005-12-02 | 2016-03-01 | Ulthera, Inc. | Systems and devices for selective cell lysis and methods of using same |
US10548659B2 (en) | 2006-01-17 | 2020-02-04 | Ulthera, Inc. | High pressure pre-burst for improved fluid delivery |
US20090326439A1 (en) * | 2006-01-17 | 2009-12-31 | Cabochon Aesthetics, Inc. | High pressure pre-burst for improved fluid delivery |
US9808300B2 (en) | 2006-05-02 | 2017-11-07 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US10589130B2 (en) | 2006-05-25 | 2020-03-17 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
US10213252B2 (en) | 2006-10-18 | 2019-02-26 | Vessix, Inc. | Inducing desirable temperature effects on body tissue |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US10413356B2 (en) | 2006-10-18 | 2019-09-17 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
US9039722B2 (en) | 2007-10-09 | 2015-05-26 | Ulthera, Inc. | Dissection handpiece with aspiration means for reducing the appearance of cellulite |
US10220122B2 (en) | 2007-10-09 | 2019-03-05 | Ulthera, Inc. | System for tissue dissection and aspiration |
US8540707B2 (en) * | 2007-12-21 | 2013-09-24 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Template system and methods |
US20090163910A1 (en) * | 2007-12-21 | 2009-06-25 | Sliwa John W | Template System and Methods |
WO2009085485A2 (en) * | 2007-12-21 | 2009-07-09 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Template system and methods |
WO2009085485A3 (en) * | 2007-12-21 | 2009-12-10 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Template system and methods |
US8489192B1 (en) | 2008-02-15 | 2013-07-16 | Holaira, Inc. | System and method for bronchial dilation |
US11058879B2 (en) | 2008-02-15 | 2021-07-13 | Nuvaira, Inc. | System and method for bronchial dilation |
US9125643B2 (en) | 2008-02-15 | 2015-09-08 | Holaira, Inc. | System and method for bronchial dilation |
US8731672B2 (en) | 2008-02-15 | 2014-05-20 | Holaira, Inc. | System and method for bronchial dilation |
US8961508B2 (en) | 2008-05-09 | 2015-02-24 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US10149714B2 (en) | 2008-05-09 | 2018-12-11 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8961507B2 (en) | 2008-05-09 | 2015-02-24 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US11937868B2 (en) | 2008-05-09 | 2024-03-26 | Nuvaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US9668809B2 (en) | 2008-05-09 | 2017-06-06 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8808280B2 (en) | 2008-05-09 | 2014-08-19 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8821489B2 (en) | 2008-05-09 | 2014-09-02 | Holaira, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US9327100B2 (en) | 2008-11-14 | 2016-05-03 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US8401667B2 (en) | 2008-11-17 | 2013-03-19 | Vessix Vascular, Inc. | Selective accumulation of energy with or without knowledge of tissue topography |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
US8900262B2 (en) | 2009-08-07 | 2014-12-02 | Ulthera, Inc. | Device for dissection of subcutaneous tissue |
US9358064B2 (en) | 2009-08-07 | 2016-06-07 | Ulthera, Inc. | Handpiece and methods for performing subcutaneous surgery |
US8979881B2 (en) | 2009-08-07 | 2015-03-17 | Ulthera, Inc. | Methods and handpiece for use in tissue dissection |
US8920452B2 (en) | 2009-08-07 | 2014-12-30 | Ulthera, Inc. | Methods of tissue release to reduce the appearance of cellulite |
US10271866B2 (en) | 2009-08-07 | 2019-04-30 | Ulthera, Inc. | Modular systems for treating tissue |
US8906054B2 (en) | 2009-08-07 | 2014-12-09 | Ulthera, Inc. | Apparatus for reducing the appearance of cellulite |
US9757145B2 (en) | 2009-08-07 | 2017-09-12 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9044259B2 (en) | 2009-08-07 | 2015-06-02 | Ulthera, Inc. | Methods for dissection of subcutaneous tissue |
US8900261B2 (en) | 2009-08-07 | 2014-12-02 | Ulthera, Inc. | Tissue treatment system for reducing the appearance of cellulite |
US8894678B2 (en) | 2009-08-07 | 2014-11-25 | Ulthera, Inc. | Cellulite treatment methods |
US11337725B2 (en) | 2009-08-07 | 2022-05-24 | Ulthera, Inc. | Handpieces for tissue treatment |
US10485573B2 (en) | 2009-08-07 | 2019-11-26 | Ulthera, Inc. | Handpieces for tissue treatment |
US10531888B2 (en) | 2009-08-07 | 2020-01-14 | Ulthera, Inc. | Methods for efficiently reducing the appearance of cellulite |
US11096708B2 (en) | 2009-08-07 | 2021-08-24 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
US9510849B2 (en) | 2009-08-07 | 2016-12-06 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
US9078688B2 (en) | 2009-08-07 | 2015-07-14 | Ulthera, Inc. | Handpiece for use in tissue dissection |
US8777943B2 (en) | 2009-10-27 | 2014-07-15 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8740895B2 (en) | 2009-10-27 | 2014-06-03 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9675412B2 (en) | 2009-10-27 | 2017-06-13 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US8932289B2 (en) | 2009-10-27 | 2015-01-13 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9649153B2 (en) | 2009-10-27 | 2017-05-16 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9017324B2 (en) | 2009-10-27 | 2015-04-28 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9005195B2 (en) | 2009-10-27 | 2015-04-14 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9931162B2 (en) | 2009-10-27 | 2018-04-03 | Nuvaira, Inc. | Delivery devices with coolable energy emitting assemblies |
US9149328B2 (en) | 2009-11-11 | 2015-10-06 | Holaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US11712283B2 (en) | 2009-11-11 | 2023-08-01 | Nuvaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US10610283B2 (en) | 2009-11-11 | 2020-04-07 | Nuvaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
US11389233B2 (en) | 2009-11-11 | 2022-07-19 | Nuvaira, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
US9649154B2 (en) | 2009-11-11 | 2017-05-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
WO2011112248A3 (en) * | 2010-03-08 | 2012-03-15 | Alpha Orthopaedics, Inc. | Methods and devices for real time monitoring of collagen and for altering collagen status |
WO2011112248A2 (en) * | 2010-03-08 | 2011-09-15 | Alpha Orthopaedics, Inc. | Methods and devices for real time monitoring of collagen and for altering collagen status |
US9277955B2 (en) | 2010-04-09 | 2016-03-08 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US10603066B2 (en) | 2010-05-25 | 2020-03-31 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
US8880185B2 (en) | 2010-06-11 | 2014-11-04 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
WO2012019181A1 (en) * | 2010-08-06 | 2012-02-09 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US10987164B2 (en) * | 2010-10-19 | 2021-04-27 | Michael D. Laufer | Methods and devices for diastolic assist |
US9855097B2 (en) | 2010-10-21 | 2018-01-02 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
US10342612B2 (en) | 2010-10-21 | 2019-07-09 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter apparatuses, systems, and methods for renal neuromodulation |
US9636173B2 (en) | 2010-10-21 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for renal neuromodulation |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
EP2632361B1 (en) * | 2010-10-28 | 2018-06-27 | Medtronic Ablation Frontiers LLC | Reactance changes to identify and evaluate cryo ablation lesions |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9848946B2 (en) | 2010-11-15 | 2017-12-26 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US9649156B2 (en) | 2010-12-15 | 2017-05-16 | Boston Scientific Scimed, Inc. | Bipolar off-wall electrode device for renal nerve ablation |
US11213618B2 (en) | 2010-12-22 | 2022-01-04 | Ulthera, Inc. | System for tissue dissection and aspiration |
US8439940B2 (en) | 2010-12-22 | 2013-05-14 | Cabochon Aesthetics, Inc. | Dissection handpiece with aspiration means for reducing the appearance of cellulite |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US9919144B2 (en) | 2011-04-08 | 2018-03-20 | Medtronic Adrian Luxembourg S.a.r.l. | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
US10588682B2 (en) | 2011-04-25 | 2020-03-17 | Medtronic Ardian Luxembourg S.A.R.L. | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US9579030B2 (en) | 2011-07-20 | 2017-02-28 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
US9186209B2 (en) | 2011-07-22 | 2015-11-17 | Boston Scientific Scimed, Inc. | Nerve modulation system having helical guide |
US10076238B2 (en) | 2011-09-22 | 2018-09-18 | The George Washington University | Systems and methods for visualizing ablated tissue |
US11559192B2 (en) | 2011-09-22 | 2023-01-24 | The George Washington University | Systems and methods for visualizing ablated tissue |
US10736512B2 (en) | 2011-09-22 | 2020-08-11 | The George Washington University | Systems and methods for visualizing ablated tissue |
US10716462B2 (en) | 2011-09-22 | 2020-07-21 | The George Washington University | Systems and methods for visualizing ablated tissue |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9079000B2 (en) | 2011-10-18 | 2015-07-14 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
US8951251B2 (en) | 2011-11-08 | 2015-02-10 | Boston Scientific Scimed, Inc. | Ostial renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9037259B2 (en) | 2011-12-23 | 2015-05-19 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9186211B2 (en) | 2011-12-23 | 2015-11-17 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9592386B2 (en) | 2011-12-23 | 2017-03-14 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9028472B2 (en) | 2011-12-23 | 2015-05-12 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9072902B2 (en) | 2011-12-23 | 2015-07-07 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9402684B2 (en) | 2011-12-23 | 2016-08-02 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9174050B2 (en) | 2011-12-23 | 2015-11-03 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US9433760B2 (en) | 2011-12-28 | 2016-09-06 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US10660703B2 (en) | 2012-05-08 | 2020-05-26 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
US10835305B2 (en) | 2012-10-10 | 2020-11-17 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
US10188829B2 (en) | 2012-10-22 | 2019-01-29 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US11147948B2 (en) | 2012-10-22 | 2021-10-19 | Medtronic Ardian Luxembourg S.A.R.L. | Catheters with enhanced flexibility and associated devices, systems, and methods |
US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US9827039B2 (en) | 2013-03-15 | 2017-11-28 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
US10548663B2 (en) | 2013-05-18 | 2020-02-04 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters with shafts for enhanced flexibility and control and associated devices, systems, and methods |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9943365B2 (en) | 2013-06-21 | 2018-04-17 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US10660698B2 (en) | 2013-07-11 | 2020-05-26 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US11457817B2 (en) | 2013-11-20 | 2022-10-04 | The George Washington University | Systems and methods for hyperspectral analysis of cardiac tissue |
US11202671B2 (en) | 2014-01-06 | 2021-12-21 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11154353B2 (en) | 2014-01-27 | 2021-10-26 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US10166069B2 (en) | 2014-01-27 | 2019-01-01 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters having jacketed neuromodulation elements and related devices, systems, and methods |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US9907609B2 (en) | 2014-02-04 | 2018-03-06 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US10736690B2 (en) | 2014-04-24 | 2020-08-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US11464563B2 (en) | 2014-04-24 | 2022-10-11 | Medtronic Ardian Luxembourg S.A.R.L. | Neuromodulation catheters and associated systems and methods |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10722301B2 (en) | 2014-11-03 | 2020-07-28 | The George Washington University | Systems and methods for lesion assessment |
US10143517B2 (en) | 2014-11-03 | 2018-12-04 | LuxCath, LLC | Systems and methods for assessment of contact quality |
US11559352B2 (en) | 2014-11-03 | 2023-01-24 | The George Washington University | Systems and methods for lesion assessment |
US10682179B2 (en) | 2014-11-03 | 2020-06-16 | 460Medical, Inc. | Systems and methods for determining tissue type |
US11596472B2 (en) | 2014-11-03 | 2023-03-07 | 460Medical, Inc. | Systems and methods for assessment of contact quality |
US10779904B2 (en) | 2015-07-19 | 2020-09-22 | 460Medical, Inc. | Systems and methods for lesion formation and assessment |
US11723721B2 (en) * | 2016-12-16 | 2023-08-15 | University Of Ulsan Foundation For Industry Cooperation | Apparatus and method for manufacturing surgical guide, and surgical guide |
US20190343589A1 (en) * | 2016-12-16 | 2019-11-14 | University Of Ulsan Foundation For Industry Cooperation | Apparatus and method for manufacturing surgical guide, and surgical guide |
US20210137636A1 (en) * | 2018-05-29 | 2021-05-13 | Ucl Business Ltd | Device for providing an interface between a medical instrument and a part of a human or animal body and methods of use thereof |
WO2019229430A1 (en) * | 2018-05-29 | 2019-12-05 | Ucl Business Ltd | Device for providing an interface between a medical instrument and a part of a human or animal body and methods of use thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2397370A1 (en) | 2001-08-16 |
WO2001058373A1 (en) | 2001-08-16 |
AU2001236831A1 (en) | 2001-08-20 |
US6663622B1 (en) | 2003-12-16 |
EP1253867A1 (en) | 2002-11-06 |
US20020143326A1 (en) | 2002-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6663622B1 (en) | Surgical devices and methods for use in tissue ablation procedures | |
US11304748B2 (en) | Cardiac treatment devices and methods | |
US7399300B2 (en) | Cardiac ablation devices and methods | |
US7591818B2 (en) | Cardiac ablation devices and methods | |
US7957820B2 (en) | Conduction block verification probe and method of use | |
US9101364B2 (en) | Cardiac ablation devices and methods | |
US9055959B2 (en) | Methods and devices for ablation | |
US8623010B2 (en) | Cardiac mapping instrument with shapeable electrode | |
US5891137A (en) | Catheter system having a tip with fixation means | |
CA2450075A1 (en) | Methods and devices for ablation | |
WO2005046456A2 (en) | Cardiac ablation devices and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |